{"gene":"FCGR1A","run_date":"2026-06-09T23:54:43","timeline":{"discoveries":[{"year":1994,"finding":"FcγRI (CD64) does not require its own cytoplasmic domain to mediate phagocytosis; instead, the γ-subunit of FcγRIIIA confers phagocytic function to FcγRI. Coexpression of FcγRI with the FcγRIIIA γ-subunit in COS-1 cells conferred phagocytic capability even to a cytoplasmic-domain-deleted mutant of FcγRI, demonstrating that the γ-subunit ITAM, not the FcγRI cytoplasmic tail, drives the phagocytic signal.","method":"COS-1 cell transfection with wild-type and cytoplasmic-domain-deletion mutants of FcγRI; co-transfection with γ-subunit of FcγRIIIA; IgG-coated red blood cell phagocytosis assay; tyrosine kinase inhibitor (tyrphostin 23) studies","journal":"Experimental hematology","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution in transfected cells with domain-deletion mutagenesis and orthogonal inhibitor experiments, directly mapping phagocytic signal to γ-subunit ITAM","pmids":["7516890"],"is_preprint":false},{"year":1996,"finding":"Extracellular domain mutations in the NOD mouse FcγRI increase IgG affinity ~10-fold (via a profoundly reduced dissociation rate) while reducing surface expression to one-tenth of wild-type. The expression level differences map to the extracellular region, and mouse FcγRI can associate with the FcεRI γ-subunit analogously to human FcγRI.","method":"Kinetic binding analysis (association/dissociation rates) of NOD vs BALB/c FcγRI; COS-7 transfection with chimeric extracellular domain swaps; co-transfection with FcεRI γ-subunit","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (kinetics, mutagenesis, domain-swap chimeras) in a single rigorous study","pmids":["8663283"],"is_preprint":false},{"year":1998,"finding":"FcγRIa-γ-chain complexes expressed in IIA1.6 cells trigger both phagocytosis and ADCC, and an intact ITAM in either the FcR γ-chain or FcγRIIa is essential for triggering these biological functions via the FcγRIa complex.","method":"Transfection of FcγRIa and γ-chain constructs into IIA1.6 cells; ITAM mutagenesis; phagocytosis of Staphylococcus aureus; ADCC of erythrocytes","journal":"Clinical and experimental immunology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — ITAM mutagenesis combined with two functional assays (phagocytosis and ADCC) in a reconstitution system","pmids":["9737671"],"is_preprint":false},{"year":1998,"finding":"The unique high-affinity IgG2a binding of FcγRI (CD64) is conferred by the specific interaction between extracellular domains 2 and 3; domain 1 plays a supporting role in conformational stability. Replacement of domains 2 and 3 of FcγRII with those of FcγRI reconstitutes specific high-affinity monomeric IgG2a binding.","method":"Domain-swap chimeric receptors generated between mouse FcγRI and mouse FcγRII; IgG binding studies with monomeric IgG2a, IgG1, and IgG2b","journal":"Molecular immunology","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic domain-swap mutagenesis with direct IgG binding measurements identifying the structural basis of high-affinity binding","pmids":["9881694"],"is_preprint":false},{"year":1999,"finding":"The FcγRIa α-chain cytoplasmic tail contains autonomous targeting information directing internalized receptor-antigen complexes to MHC class II-containing late endosomes for antigen presentation, independently of the FcR γ-chain ITAM. Deletion of the cytoplasmic tail diverts complexes to the recycling pathway and decreases antigen presentation, demonstrating a functional role for the tail distinct from canonical tyrosine/dileucine motifs.","method":"IIA1.6 cell transfection with FcγRIa constructs (wild-type, ITAM-mutant γ-chain, cytoplasmic-tail deletion); immunoelectron microscopy tracking receptor-ligand complex trafficking; MHC class II antigen presentation assay","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1 / Strong — immunoelectron microscopy plus domain-deletion mutagenesis plus functional antigen-presentation readout in a single study","pmids":["10397749"],"is_preprint":false},{"year":1999,"finding":"The cytoplasmic domain (CY) of FcγRIa α-chain directly modulates the functional properties of the receptor complex: CY deletion slows kinetics of receptor-specific phagocytosis and endocytosis, converts calcium-independent phagocytosis to calcium-dependent phagocytosis, and abrogates FcγRIa-specific IL-6 secretion without affecting IL-1β production.","method":"Stable transfectants in murine macrophages expressing full-length or CY-deletion mutant FcγRIa; IgG-opsonized particle phagocytosis assay; calcium measurement; cytokine ELISA","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — domain-deletion mutagenesis with multiple orthogonal functional readouts (kinetics, calcium dependency, cytokine output)","pmids":["10514529"],"is_preprint":false},{"year":1999,"finding":"FcγRI aggregation in IFN-γ-primed U937 cells activates the novel PKC isoenzymes δ, ε, and atypical PKC ζ (calcium-independent), whereas in cells differentiated to a macrophage phenotype it activates conventional calcium-dependent PKCs α, β, and γ, consistent with differentiation-state-dependent coupling to distinct phospholipase pathways.","method":"PKC activity assays and translocation studies in IFN-γ-primed vs dbcAMP-differentiated U937 cells after FcγRI aggregation; isoenzyme-specific fractionation","journal":"Immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-based functional assays with isoenzyme fractionation, single lab, two differentiation states","pmids":["10233728"],"is_preprint":false},{"year":2002,"finding":"The serine residues in the FcγRIa α-chain cytoplasmic domain are constitutively phosphorylated and this phosphorylation regulates early tyrosine-phosphorylation cascades and phagocytosis; mutation of cytoplasmic serine residues to alanine abolishes okadaic acid (phosphatase inhibitor) inhibition of phagocytosis, while cytoplasmic domain truncation and serine mutations have distinct effects on cytokine production vs. phagocytosis.","method":"FcγRIa molecular variants (serine→alanine mutants, truncation mutants) expressed in murine macrophage P388D1 cells; okadaic acid treatment; phagocytosis assay; tyrosine phosphorylation immunoblot","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic mutagenesis of the cytoplasmic domain with multiple functional and biochemical readouts establishing serine phosphorylation as a regulatory mechanism","pmids":["12200451"],"is_preprint":false},{"year":2002,"finding":"FcγRI is required for IgG2a immune complex-induced phagocytosis, cytokine release, cellular cytotoxicity, and antigen presentation in vivo; FcγRI-deficient mice show impaired hypersensitivity responses, reduced cartilage destruction in arthritis, and impaired protection from bacterial infection.","method":"FcγRI knockout mouse studies across multiple in vivo models (hypersensitivity, collagen-induced arthritis, bacterial infection); comparison with FcγRIII-KO and complement-deficient mice","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function in multiple disease models with specific cellular and immunological phenotypes, replicated across independent labs (two papers same year)","pmids":["11911824","11911823"],"is_preprint":false},{"year":2002,"finding":"FcγRI is the primary mediator of endocytosis of monomeric IgG; in its absence, kinetics and extent of immune complex phagocytosis are impaired, macrophage-based ADCC is impaired, and immune complex-dependent antigen presentation to T cells is reduced. FcγRI-deficient mice also show elevated antibody responses, implying FcγRI acts as a control point for antibody production. Additionally, FcR-γ-chain-deficient mice express a partially functional FcγRI.","method":"FcγRI knockout mouse generation (gene targeting); in vitro phagocytosis, ADCC, and antigen-presentation assays; in vivo antibody response measurements","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with multiple orthogonal functional readouts, independent replication","pmids":["11911823"],"is_preprint":false},{"year":2002,"finding":"C-reactive protein (CRP) binds directly to the extracellular portion of FcγRI with approximately 3-fold higher affinity than IgG (KD ≈ 0.81 nM) in a calcium-dependent manner. CRP opsonization of phosphorylcholine-coated erythrocytes induces phagocytosis via FcγRI/γ-chain transfectants and activates phospholipase D in IFN-γ-treated U937 cells, indicating CRP can crosslink FcγRI to trigger signaling.","method":"BIAcore surface plasmon resonance for binding kinetics; COS-7 transfection with FcγRI chimeras; phagocytosis assay; phospholipase D activation in U937 cells; IgG1 competition and calcium chelation experiments","journal":"Immunology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct binding kinetics plus functional phagocytosis and signaling assays in a single study, single lab","pmids":["12383205"],"is_preprint":false},{"year":2004,"finding":"Periplakin (PPL) selectively interacts with the intracellular cytoplasmic tail of the FcγRI α-chain (but not other activatory FcRs). This interaction controls FcγRI ligand binding capacity, endocytosis, and antigen presentation; PPL and FcγRI co-localize at the plasma membrane of monocytes, and both are upregulated by IFN-γ.","method":"Co-immunoprecipitation; blot-overlay assay; confocal co-localization in monocytes and transfectants; overexpression of C-terminal PPL to assess FcγRI functional outcomes (ligand binding, endocytosis, antigen presentation)","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, blot-overlay, co-localization, and multiple functional readouts confirming the interaction and its consequence","pmids":["15229321"],"is_preprint":false},{"year":2004,"finding":"TAT-peptides that block FcγRI–periplakin interaction modulate FcγRI ligand-binding capacity (assessed by erythrocyte-antibody rosetting), demonstrating a dominant-negative role for C-terminal periplakin in FcγRI biological activity. Alanine-substitution mapping of the FcγRI cytoplasmic tail and random mutagenesis of periplakin defined the specific interaction domains.","method":"Truncated and alanine-substituted FcγRI mutants; randomly mutagenized periplakin; TAT-peptide blocking of endogenous FcγRI–periplakin interaction; erythrocyte-antibody rosetting assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — systematic mutagenesis of both binding partners with cell-permeant peptide interference and functional readout, single lab","pmids":["15161926"],"is_preprint":false},{"year":2004,"finding":"FcγRI can use FcγRIIa (R131 or H131 allele) to phagocytose IgG- or CRP-opsonized erythrocytes in the absence of the FcR γ-chain; this phagocytosis requires the cytoplasmic ITAM of FcγRIIa (mutation of Y205 or cytoplasmic truncation abrogates phagocytosis). COS-7 cells expressing FcγRI or FcγRIIa alone do not phagocytose.","method":"COS-7 transfection with FcγRI alone, FcγRIIa alone, or co-transfection; ITAM-mutant FcγRIIa (Y205 mutation and cytoplasmic truncation); erythrocyte phagocytosis assay; CRP and IgG opsonization","journal":"Journal of leukocyte biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution in transfected cells with ITAM mutagenesis and two opsonin conditions, mapping phagocytic requirement to FcγRIIa ITAM","pmids":["15075346"],"is_preprint":false},{"year":2004,"finding":"FcγRI and FcγRIIa differ in their interaction with Syk kinase: FcγRIIA interacts more readily with Syk than the FcγRI/γ-chain complex, contributing to greater phagocytic efficiency of FcγRIIA. Individual Src-related tyrosine kinases (Hck, Lyn) differentially affect phagocytosis and Syk interaction for each receptor.","method":"COS-1 cell transfection with FcγRI-γ-γ chimera vs FcγRIIA; co-IP with Syk, Hck, and Lyn; phagocytosis assay with IgG-coated red blood cells","journal":"Journal of leukocyte biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-immunoprecipitation plus functional phagocytosis readout; single lab","pmids":["15136586"],"is_preprint":false},{"year":2006,"finding":"FcγRIA (CD64)-mediated enhancement of dengue virus immune complex infectivity requires signaling competency (intact ITAM) in the accessory γ-chain; abrogation of FcγRIA signaling (by expression without γ-chain or coexpression with ITAM-mutant γ-chain) significantly impairs both phagocytosis and dengue virus immune complex infectivity. This contrasts with FcγRIIA where signaling abrogation impairs phagocytosis but not dengue immune complex infectivity.","method":"ITAM tyrosine mutagenesis by site-directed mutagenesis; COS-7 transfection with native and signaling-incompetent FcγRIA/FcγRIIA; dengue virus replication measured by plaque assay and flow cytometry","journal":"Journal of virology","confidence":"High","confidence_rationale":"Tier 1 / Strong — site-directed ITAM mutagenesis in reconstituted system with two independent readouts (phagocytosis and viral replication), comparison of two receptor types","pmids":["17005690"],"is_preprint":false},{"year":2007,"finding":"C-reactive protein binds to FcγRI on intact cells with KD ~10 µM; co-expression of the γ-chain markedly increases CRP affinity to FcγRI (~30-fold enhanced association rate, KD ~0.35 µM), suggesting the γ-chain mediates critical transmembrane interactions that enhance CRP binding to FcγRI. Dissociation of CRP from cell surfaces is extremely slow, indicating multivalent binding and receptor clustering.","method":"Ultrasensitive confocal imaging analysis (single-molecule); COS-7 transfection with FcγRI alone or FcγRI+γ-chain; binding kinetics measurement","journal":"The American journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — quantitative single-molecule binding kinetics in transfected cells comparing two receptor configurations, single lab","pmids":["17255341"],"is_preprint":false},{"year":2008,"finding":"FcγRI (CD64) constitutively resides within lipid raft microdomains (detergent-insoluble buoyant membranes) together with FcR γ-chain, independent of crosslinking ligand. Cholesterol depletion modulates FcγRI-ligand interactions, and FcγRI co-patches with GM1 glycolipid by confocal imaging.","method":"Detergent-insoluble membrane fractionation; confocal co-patching with GM1; cholesterol depletion experiments; ligand-binding assay after cholesterol depletion","journal":"Immunology letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical fractionation with confocal imaging and functional consequence (ligand binding) upon cholesterol depletion; single lab","pmids":["18207250"],"is_preprint":false},{"year":2008,"finding":"Recombinant soluble human FcγRIA (CD64A) binds IgG with high affinity (KD = 1.7×10⁻¹⁰ M), blocks immune complex precipitation, inhibits complement-mediated lysis of antibody-sensitized RBCs, and suppresses immune complex-mediated IL-6, IL-13, MCP-1, and TNF-α production by mast cells. Local or systemic delivery of soluble FcγRIA reduces edema and neutrophil infiltration in the Arthus reaction and prevents joint damage in collagen antibody-induced arthritis in mice.","method":"Surface plasmon resonance for binding kinetics; in vitro mast cell cytokine assay; murine Arthus reaction model; collagen antibody-induced arthritis model; 125I-radiolabeling for pharmacokinetics","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct binding kinetics plus multiple in vitro and in vivo functional assays demonstrating the decoy mechanism of soluble FcγRIA","pmids":["18097060"],"is_preprint":false},{"year":2009,"finding":"FcγRI activation triggers a novel signaling cascade linking phospholipase D1 to sphingosine kinase-1 in U937 cells and primary human monocytes, inducing proinflammatory mediator expression and trafficking of immune complexes into HLA-DM-positive antigen-processing compartments with improved MHC class II antigen presentation. This pathway is distinct from FcγRIIA signaling (which uses phospholipase Cγ1 and induces oxidative burst).","method":"Pharmacological inhibitor studies (PLD1, SK1); subcellular trafficking analysis with HLA-DM compartment co-localization; cytokine measurement; MHC class II antigen presentation assay; comparison between FcγRI and FcγRIIA activation","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal signaling readouts (PLD1→SK1 pathway, trafficking, antigen presentation, cytokine) with direct pathway comparison using primary human cells and cell lines","pmids":["19420354"],"is_preprint":false},{"year":2010,"finding":"The FcγRI α-chain (CD64) interacts with OmpA of E. coli K1 independently of IgG opsonization; this interaction requires the full-length α-chain cytoplasmic domain (C-terminal truncation prevents E. coli entry). OmpA binding to FcγRIa prevents γ-chain recruitment and induces a different tyrosine phosphorylation pattern compared with IgG2a-induced phosphorylation. FcγRIa-deficient mice are resistant to E. coli K1 meningitis with accelerated bacterial clearance and increased CR3 expression on macrophages.","method":"FcγRIa(-/-) mouse model; overexpression of full-length and C-terminal truncated FcγRIa in COS-1 cells; adoptive macrophage transfer; co-IP to assess γ-chain recruitment; tyrosine phosphorylation immunoblot; CR3 expression flow cytometry","journal":"PLoS pathogens","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO plus domain mutagenesis plus multiple mechanistic readouts (γ-chain recruitment, phosphorylation pattern, adoptive transfer) across in vitro and in vivo systems","pmids":["21124939"],"is_preprint":false},{"year":2010,"finding":"FcγRI mediates serum amyloid P (SAP)-induced inhibition of fibrocyte differentiation; deletion of FcγRI (CD64) in murine cells or siRNA-mediated knockdown in human cells significantly reduces sensitivity to SAP. The inhibitory receptor FcγRIIb increases sensitivity to SAP, whereas deletion of FcγRIIb, FcγRIIIa, and FcγRIV together does not affect SAP sensitivity.","method":"FcγRI-knockout murine cells; siRNA knockdown of FcγRI and FcRγ in human cells; fibrocyte differentiation assay; SAP mutagenesis (residues critical for FcγRIIa binding); genetic deletion combinations","journal":"Journal of leukocyte biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO and siRNA KD with specific functional readout (fibrocyte differentiation); single lab with multiple deletion combinations","pmids":["22493081"],"is_preprint":false},{"year":2012,"finding":"FcγRI (CD64) activation drives NF-κB-regulated NLRP3 inflammasome formation and IL-1β/IL-18 release; FcγRI-expressing Ba/F3 cells show increased NLRP3 inflammasome formation reversed by NF-κB inhibitor PDTC. Silencing FcγRI in THP-1 macrophages reduces NLRP3 inflammasome activation.","method":"FcγRI-expressing Ba/F3 cell model; NF-κB inhibitor (PDTC) treatment; siRNA knockdown of FcγRI in THP-1 macrophages; NLRP3 inflammasome protein expression; IL-1β and IL-18 ELISA","journal":"Life sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function and loss-of-function with pathway inhibition linking FcγRI to NF-κB/NLRP3 axis; single lab","pmids":["29920250"],"is_preprint":false},{"year":2015,"finding":"Crystal structure of human FcγRI in complex with IgG-Fc reveals the molecular basis for high-affinity binding; a receptor-glycan interaction involving the third extracellular domain contributes importantly to binding affinity. This structural work illuminates how the three-domain architecture of FcγRI achieves high affinity compared to two-domain low-affinity receptors.","method":"Structural determination (crystallography of FcγRI–IgG-Fc complex); structural analysis of receptor-glycan contacts","journal":"Immunological reviews","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — structural data (crystal structure) reported in a review/summary paper; the primary structure data is referenced but the abstract is a review without independent validation described","pmids":["26497521"],"is_preprint":false},{"year":2015,"finding":"Binding of monomeric IgG to FcγRI provides a low-intensity tonic signal necessary for full IFN-γ receptor signaling in the same cell. Engagement of FcγRI with larger immune complexes results in phagocytosis, reactive oxygen species generation, and inflammatory cytokine synthesis, but FcγRI engagement can also potently inhibit IFNγ and TLR4 signaling and induce IL-10 secretion depending on context.","method":"Review synthesizing published experimental evidence including receptor signaling studies (tonic signal, IFNγ receptor crosstalk, TLR4 inhibition assays)","journal":"Immunological reviews","confidence":"Low","confidence_rationale":"Tier 3 / Weak — review paper summarizing experimental findings from multiple sources; individual underlying experiments not independently assessable from this abstract alone","pmids":["26497519"],"is_preprint":false},{"year":2016,"finding":"LILRB4 co-ligation with FcγRI significantly dephosphorylates key signaling proteins in the clathrin-mediated endocytosis and Fc-receptor phagocytosis pathways (including FcR γ-chain, Syk, clathrin, Cbl, HRS, TRIM21, and HSP70), suppressing antibody-opsonized bacterial particle uptake, demonstrating that tyrosine phosphorylation of these proteins is critical for FcγRI-dependent endocytosis/phagocytosis.","method":"Antibody ligation of FcγRI and/or LILRB4 on THP-1 cells; anti-phosphotyrosine immunoprecipitation; mass spectrometry peptide sequencing (Mascot); Ingenuity Pathway Analysis; bacterial particle phagocytosis assay","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — phosphoproteomics by MS combined with functional phagocytosis readout; single lab","pmids":["27725776"],"is_preprint":false},{"year":2017,"finding":"FcγRI (FcγRIa, CD64) nanoclusters at macrophage surfaces are constitutively associated (within 62 ± 5 nm) with SIRPα nanoclusters via the actin cytoskeleton. Upon Fc receptor activation, Src-family kinase signaling causes segregation of FcγRI and SIRPα nanoclusters (to 197 ± 3 nm apart). Co-ligation of SIRPα with CD47 abrogates nanocluster segregation. If activation signals dominate, FcγRI nanoclusters reorganize into periodically spaced concentric rings.","method":"Dual-color direct stochastic optical reconstruction microscopy (dSTORM) super-resolution imaging; Src-family kinase inhibitor treatment; CD47-SIRPα co-ligation; actin cytoskeleton disruption","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — super-resolution structural imaging combined with pharmacological and co-ligation experiments with nanometer-scale precision, revealing mechanistic basis of signal integration","pmids":["28289091"],"is_preprint":false},{"year":2018,"finding":"Cytokines (IL-3, TNFα, IFNγ) enhance FcγRI binding to immune complexes through 'inside-out' signaling that increases FcγRI nanoclustering in an actin-cytoskeleton-dependent manner. Chemical inhibition of PP1 phosphatase activity reduces FcγRI inside-out signaling (without altering FcγRI phosphorylation itself), and TNFα/IFNγ stimulation enhances neutrophil ADCC toward CD20-expressing tumor cells.","method":"Super-resolution imaging (single-particle tracking); PP1 phosphatase inhibitor (calyculin A); actin cytoskeleton disruption; cytokine stimulation (IL-3, TNFα, IFNγ); ADCC assay against CD20+ tumor cells","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 1 / Strong — super-resolution imaging combined with pharmacological dissection of signaling and functional ADCC readout in primary human cells","pmids":["30042128"],"is_preprint":false},{"year":2019,"finding":"FcγRI (CD64) expressed in a subpopulation of joint sensory neurons directly mediates acute joint hypernociception upon IgG immune complex crosslinking, independently of joint inflammation. FcγRI crosslinking directly activates somata and peripheral terminals of these neurons. Effects are diminished in global and sensory-neuron-specific Fcgr1 knockout mice. In murine inflammatory arthritis models, neuronal FcγRI signaling is upregulated and its acute blockade or genetic deletion attenuates arthritis pain without altering joint inflammation.","method":"Global and conditional (sensory neuron-specific) Fcgr1 knockout mice; IgG immune complex-induced joint hypernociception model; inflammatory arthritis models; electrophysiology of joint sensory neurons; pain behavioral assays","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO in sensory neurons with multiple behavioral and electrophysiological readouts demonstrating neuronal-cell-autonomous function, independent of immune cell FcγRI","pmids":["31211699"],"is_preprint":false},{"year":2019,"finding":"Deglycosylation of antibody-based radioimmunoconjugates impairs their binding to FcγRI (surface plasmon resonance, ELISA, flow cytometry), resulting in ~3.5-fold reduction in off-target liver uptake and improved tumor-to-organ contrast in PET imaging in humanized NSG mice, demonstrating that FcγRI-mediated sequestration in immune cells drives hepatic off-target uptake of radioimmunoconjugates.","method":"Surface plasmon resonance (SPR); ELISA; flow cytometry; 89Zr-labeling; PET imaging; biodistribution in athymic nude, NSG, and humanized NSG mice bearing HER2+ xenografts","journal":"Journal of nuclear medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct SPR binding plus in vivo functional consequence (biodistribution) with three mouse model types; multiple orthogonal methods","pmids":["30733320"],"is_preprint":false},{"year":2021,"finding":"FcγRI potentiates HIV-1 neutralization by antibodies targeting the gp41 NHR region >5,000-fold in TZM-bl cells expressing FcγRI compared to cells without it, enabling neutralization of tier-2 viruses. This FcγRI-dependent potentiation is also observed with antisera from guinea pigs immunized with an NHR-based vaccine candidate.","method":"Neutralization assay in TZM-bl cells with and without FcγRI expression; comparison of tier-1 and tier-2 virus neutralization; guinea pig immunization with (ccIZN36)3 vaccine; FcγRI-blocking controls","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-based neutralization assay with FcγRI-expressing vs. control cells plus in vivo antisera testing; single lab","pmids":["33431684"],"is_preprint":false},{"year":2022,"finding":"FCGR1A variants affect CD64 function: (1) SNV rs1848781 in the proximal promoter region associates with CD64 expression levels (confirmed by promoter reporter assay showing higher activity of G vs C allele); (2) rs587598788 indel in intron 5 associates with CD64 expression; (3) non-synonymous SNV rs1050204 (p.D324N) significantly affects CD64-mediated phagocytosis, degranulation, and pro-inflammatory cytokine production.","method":"Promoter reporter assay; genotype-phenotype association analysis; functional assays for CD64-mediated phagocytosis, degranulation, and cytokine production with rs1050204 variant","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter reporter assay plus functional phagocytosis/cytokine assays for coding variant; single lab, human genetic variants","pmids":["35371020"],"is_preprint":false},{"year":2023,"finding":"CD64 overexpression in allogeneic iPSC-derived endothelial cells enables escape from antibody-mediated killing (ADCC and complement-dependent cytotoxicity) by capturing monomeric IgG and occupying Fc regions. An intracellularly truncated CD64 analog (CD64t) retains this protective function, demonstrating that Fc capture rather than intracellular signaling is the mechanistic basis of protection.","method":"In vitro ADCC and complement-dependent cytotoxicity assays; humanized mouse ADCC models; overexpression of full-length CD64 vs. intracellularly truncated CD64t; iPSC-derived endothelial cells, thyroid epithelial cells, beta cells, and CAR T cells","journal":"Nature biotechnology","confidence":"High","confidence_rationale":"Tier 2 / Strong — truncation mutagenesis distinguishing signaling from IgG-capture function, validated in multiple cell types and in vivo humanized mouse models","pmids":["36593395"],"is_preprint":false},{"year":2023,"finding":"Neuronal FcγRI in dorsal root ganglion (DRG) neurons mediates neuropathic pain; sciatic nerve injury persistently activates FcγRI-related signaling in DRG, and conditional knockout of Fcgr1 in DRG neurons significantly alleviates neuropathic pain. CRP, which increases in DRG after nerve injury, evokes pain by activating neuronal FcγRI. Microinjection of naive IgG into DRG alleviates neuropathic pain by suppressing neuronal FcγRI activation, indicating IgG acts as a competitive inhibitor at neuronal FcγRI.","method":"Conditional knockout (CKO) of Fcgr1 in DRG neurons (rat model); nerve injury model (CCI); DRG microinjection of CRP and naive IgG; behavioral pain assays; FcγRI signaling pathway analysis in DRG neurons","journal":"Advanced science","confidence":"High","confidence_rationale":"Tier 2 / Strong — neuron-specific conditional KO with multiple mechanistic interventions (CRP, IgG injection) and behavioral readouts establishing neuronal FcγRI signaling in pain","pmids":["36727833"],"is_preprint":false},{"year":2025,"finding":"Guselkumab, via its native Fc domain, binds FcγRI (CD64) on IFN-γ-primed monocytes and simultaneously captures IL-23 secreted from CD64+ IL-23-producing macrophages, mediating IL-23 internalization into low-pH intracellular compartments. This Fc-mediated CD64 binding enhances potency for inhibiting IL-23 signaling in a co-culture system where IL-23 is produced by CD64+ cells, compared to risankizumab (which has Fc mutations abrogating FcγR binding).","method":"Flow cytometry (Fc-mediated binding to CD64+ monocytes); live-cell confocal imaging (IL-23 internalization into low-pH compartments); co-culture of IL-23-producing CD64+ THP-1 cells with IL-23-responsive reporter cells; Fc-blocking controls","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — live imaging plus co-culture functional assay with Fc-blocking controls; single lab, in vitro only","pmids":["40145093"],"is_preprint":false}],"current_model":"FcγRI (CD64, FCGR1A) is the sole human high-affinity IgG Fc receptor, functioning as a complex of a three-extracellular-domain α-chain (domains 2 and 3 conferring high-affinity IgG binding) with the FcR γ-chain, which supplies the ITAM required for phagocytosis, ADCC, and most signaling; the α-chain cytoplasmic tail, phosphorylated on serine residues, modulates kinetics of endocytosis and cytokine specificity through interactions with periplakin, constitutively resides in lipid rafts, and contains autonomous targeting information directing antigen to MHC class II compartments independently of the γ-chain ITAM; cytokine-driven 'inside-out' signaling clusters FcγRI nanoclusters via the actin cytoskeleton (regulated by PP1 phosphatase), enhancing immune complex binding, while activation segregates FcγRI from inhibitory SIRPα nanoclusters; downstream signaling proceeds through a PLD1→sphingosine kinase-1 cascade (distinct from FcγRIIA's PLCγ1 pathway), activates NF-κB/NLRP3 inflammasome, and differentially recruits PKC isoenzymes depending on cell differentiation state; beyond classical myeloid cells, FcγRI expressed in sensory neurons directly mediates IgG immune complex-induced joint pain and neuropathic pain through neuronal CRP/FcγRI signaling, and CRP binds FcγRI with affinity enhanced ~30-fold by the γ-chain, triggering phagocytosis and PLD activation."},"narrative":{"mechanistic_narrative":"FCGR1A (Fcγ RI, CD64) is the high-affinity IgG Fc receptor that drives antibody-dependent effector functions of myeloid cells, including phagocytosis, ADCC, antigen presentation, and proinflammatory cytokine output [PMID:11911824, PMID:11911823]. High-affinity, IgG-subclass-specific binding is conferred by the receptor's extracellular domains 2 and 3, with domain 1 supporting conformational stability and a domain-3 receptor-glycan contact contributing to affinity [PMID:9881694, PMID:26497521]. The α-chain itself lacks signaling motifs: phagocytosis, ADCC, and enhancement of immune-complex viral infectivity all require an ITAM supplied in trans by the associated FcR γ-chain (or, in its absence, by Fcγ RIIa), and abrogating that ITAM uncouples signaling from receptor engagement [PMID:7516890, PMID:9737671, PMID:15075346, PMID:17005690]. The α-chain cytoplasmic tail carries an autonomous, γ-chain-independent function: it is constitutively serine-phosphorylated, sets the kinetics of endocytosis/phagocytosis and the calcium dependence and cytokine specificity of responses (notably IL-6 secretion), and routes internalized antigen to MHC class II late-endosomal compartments — activities mediated in part through a selective interaction with periplakin [PMID:10397749, PMID:10514529, PMID:12200451, PMID:15229321, PMID:15161926]. Downstream of aggregation, Fcγ RI signals through a phospholipase D1→sphingosine kinase-1 cascade distinct from the PLCγ1 pathway of Fcγ RIIa, recruits PKC isoenzymes in a differentiation-state-dependent manner, and drives NF-κB-regulated NLRP3 inflammasome activation and IL-1β/IL-18 release [PMID:10233728, PMID:19420354, PMID:29920250]. The receptor resides constitutively in lipid rafts and organizes into nanoclusters whose immune-complex avidity is tuned by cytokine-driven, actin-dependent 'inside-out' signaling (regulated by PP1) and whose proximity to inhibitory SIRPα nanoclusters reorganizes upon activation [PMID:18207250, PMID:28289091, PMID:30042128]. C-reactive protein is a non-IgG ligand that binds the Fcγ RI extracellular region with affinity strongly enhanced by the γ-chain, triggering phagocytosis and PLD activation [PMID:12383205, PMID:17255341]. Beyond myeloid cells, Fcγ RI in sensory neurons cell-autonomously mediates IgG immune-complex-induced joint pain and CRP-driven neuropathic pain [PMID:31211699, PMID:36727833]. Coding and regulatory FCGR1A variants modulate CD64 expression and effector function [PMID:35371020].","teleology":[{"year":1994,"claim":"Established that Fcγ RI lacks intrinsic signaling capacity and depends on an associated subunit, answering how a receptor with a short tail triggers phagocytosis.","evidence":"COS-1 reconstitution of wild-type and cytoplasmic-deletion Fcγ RI with the Fcγ RIIIA γ-subunit plus tyrosine kinase inhibitor studies","pmids":["7516890"],"confidence":"High","gaps":["Did not define the γ-chain ITAM tyrosines required","Phagocytosis assayed in a non-myeloid heterologous cell line"]},{"year":1996,"claim":"Mapped expression and IgG-affinity determinants to the extracellular region and showed conserved γ-chain association across species, framing the structural basis of high-affinity binding.","evidence":"Kinetic binding analysis of NOD vs BALB/c Fcγ RI, COS-7 extracellular domain-swap chimeras, and co-transfection with the Fcε RI γ-subunit","pmids":["8663283"],"confidence":"High","gaps":["Mouse receptor; human affinity determinants inferred","Mechanism linking extracellular mutations to surface expression unresolved"]},{"year":1998,"claim":"Defined that an intact ITAM in either the γ-chain or Fcγ RIIa is essential for triggering phagocytosis and ADCC, and that extracellular domains 2/3 confer high-affinity subclass-specific binding.","evidence":"ITAM mutagenesis and reconstitution in IIA1.6 cells with phagocytosis/ADCC readouts; domain-swap chimeras with monomeric IgG binding","pmids":["9737671","9881694"],"confidence":"High","gaps":["Did not resolve which kinases read the ITAM","Domain-3 glycan contribution not yet identified"]},{"year":1999,"claim":"Resolved an autonomous, γ-chain-independent role for the α-chain cytoplasmic tail in trafficking and cytokine specificity, distinguishing it from the ITAM-driven phagocytic signal.","evidence":"IIA1.6 and macrophage transfectants with tail-deletion and ITAM-mutant constructs, immunoelectron microscopy, MHC-II antigen presentation, calcium and cytokine assays; PKC isoenzyme fractionation in differentiated U937 cells","pmids":["10397749","10514529","10233728"],"confidence":"High","gaps":["Trafficking motifs within the tail not pinpointed","Link between PKC isoenzyme usage and downstream phospholipases not directly tested"]},{"year":2002,"claim":"Established constitutive serine phosphorylation of the α-chain tail as a regulatory layer and demonstrated the receptor's non-redundant in vivo roles in effector function and antibody control.","evidence":"Serine→alanine and truncation mutants in P388D1 macrophages with okadaic acid; Fcγ RI knockout mice across hypersensitivity, arthritis, and infection models; CRP direct binding by SPR and functional phagocytosis/PLD assays","pmids":["12200451","11911824","11911823","12383205"],"confidence":"High","gaps":["Serine kinase(s) acting on the tail not identified","CRP versus IgG binding-site overlap on the receptor unresolved"]},{"year":2004,"claim":"Identified periplakin as a selective α-chain cytoplasmic-tail partner controlling ligand binding and trafficking, and dissected receptor-proximal kinase differences from Fcγ RIIa.","evidence":"Reciprocal co-IP, blot-overlay, alanine-scanning and TAT-peptide interference for periplakin; Syk/Hck/Lyn co-IP and γ-chain-independent Fcγ RIIa-ITAM phagocytosis in COS cells","pmids":["15229321","15161926","15075346","15136586"],"confidence":"High","gaps":["How periplakin mechanistically alters ligand-binding capacity unclear","Functional significance of weaker Syk recruitment in primary myeloid cells not established"]},{"year":2006,"claim":"Showed that Fcγ RI signaling competency (γ-chain ITAM) is required for antibody-dependent enhancement of dengue infectivity, extending its functional repertoire beyond simple uptake.","evidence":"Site-directed ITAM mutagenesis in COS-7 with dengue plaque and flow-cytometric infectivity readouts versus Fcγ RIIa","pmids":["17005690"],"confidence":"High","gaps":["Signaling step coupling ITAM to enhanced viral entry unresolved","Heterologous cell system may not reflect primary monocytes"]},{"year":2007,"claim":"Quantified γ-chain enhancement of CRP binding (~30-fold), revealing a transmembrane contribution to non-IgG ligand engagement.","evidence":"Single-molecule confocal binding kinetics in COS-7 cells expressing Fcγ RI alone or with γ-chain","pmids":["17255341"],"confidence":"Medium","gaps":["Structural basis of γ-chain transmembrane contribution not defined","Single lab, heterologous cells"]},{"year":2008,"claim":"Localized Fcγ RI to lipid rafts and demonstrated a soluble receptor decoy strategy, addressing membrane organization and therapeutic potential.","evidence":"Detergent-insoluble membrane fractionation and GM1 co-patching; recombinant soluble Fcγ RIA SPR binding plus mast-cell cytokine, Arthus, and arthritis models","pmids":["18207250","18097060"],"confidence":"Medium","gaps":["Functional consequence of raft residence for signaling not fully defined","Decoy efficacy translation to human disease untested"]},{"year":2009,"claim":"Defined a Fcγ RI-specific PLD1→sphingosine kinase-1 signaling axis driving inflammatory mediators and MHC-II trafficking, distinct from Fcγ RIIa's PLCγ1 pathway.","evidence":"Pharmacological PLD1/SK1 inhibition, HLA-DM compartment co-localization, cytokine and antigen-presentation assays in U937 cells and primary human monocytes","pmids":["19420354"],"confidence":"High","gaps":["Connection between γ-chain ITAM and PLD1 activation not mapped","Inhibitor-based pathway dissection lacks genetic confirmation"]},{"year":2010,"claim":"Revealed an IgG-independent role of the α-chain cytoplasmic tail in bacterial OmpA recognition and identified Fcγ RI as a control point in fibrocyte differentiation, broadening its ligand and effector scope.","evidence":"Fcγ RIa knockout mice in E. coli K1 meningitis with tail-truncation, γ-chain recruitment co-IP, phosphorylation analysis, and adoptive transfer; Fcγ RI KO/siRNA in SAP-driven fibrocyte differentiation assays","pmids":["21124939","22493081"],"confidence":"High","gaps":["Signaling pathway downstream of OmpA-induced phosphorylation undefined","SAP-Fcγ RI binding interface not characterized"]},{"year":2012,"claim":"Linked Fcγ RI activation to NF-κB-dependent NLRP3 inflammasome assembly and IL-1β/IL-18 release, connecting the receptor to inflammasome biology.","evidence":"Gain-of-function in Ba/F3 cells with PDTC inhibition and siRNA knockdown in THP-1 macrophages with inflammasome protein and cytokine readouts","pmids":["29920250"],"confidence":"Medium","gaps":["Intermediate signaling between Fcγ RI and NF-κB not mapped","Single lab"]},{"year":2015,"claim":"Provided structural and signaling-context detail: a crystal structure of the IgG-Fc complex implicating a domain-3 glycan contact, and a model of monomeric-IgG tonic signaling versus immune-complex activation.","evidence":"Crystallography of the Fcγ RI–IgG-Fc complex (reported in review); review synthesis of tonic signaling and IFN-γ/TLR4 crosstalk experiments","pmids":["26497521","26497519"],"confidence":"Medium","gaps":["Structural data reported within a review without independent validation here","Tonic-signaling mechanism summarized rather than directly demonstrated"]},{"year":2016,"claim":"Used phosphoproteomics to define the tyrosine-phosphorylation network required for Fcγ RI endocytosis/phagocytosis and showed inhibitory LILRB4 co-ligation dephosphorylates it.","evidence":"Fcγ RI/LILRB4 ligation in THP-1 cells with anti-phosphotyrosine IP, mass spectrometry, and phagocytosis assay","pmids":["27725776"],"confidence":"Medium","gaps":["Direct substrates of LILRB4-recruited phosphatase not pinpointed","Single lab"]},{"year":2018,"claim":"Demonstrated cytokine-driven, actin- and PP1-dependent 'inside-out' nanoclustering as the mechanism by which Fcγ RI avidity for immune complexes is dynamically tuned, with functional consequences for ADCC.","evidence":"Super-resolution single-particle tracking, PP1 inhibition (calyculin A), actin disruption, cytokine priming, and CD20+ tumor ADCC assay","pmids":["30042128"],"confidence":"High","gaps":["How PP1 controls clustering without altering receptor phosphorylation unresolved","Identity of clustering scaffold proteins not defined"]},{"year":2017,"claim":"Resolved spatial integration of activating and inhibitory signals by imaging constitutive Fcγ RI–SIRPα nanocluster association and their activation-dependent segregation.","evidence":"Dual-color dSTORM super-resolution imaging with Src-family kinase inhibition, CD47-SIRPα co-ligation, and actin disruption","pmids":["28289091"],"confidence":"High","gaps":["Molecular tether linking the two nanocluster types not identified","Functional output of concentric-ring reorganization not quantified"]},{"year":2019,"claim":"Established a cell-autonomous neuronal function for Fcγ RI in sensory neurons, mediating IgG immune-complex-induced joint pain independent of inflammation.","evidence":"Global and sensory-neuron-specific Fcgr1 knockout mice with electrophysiology and pain behavioral assays in immune-complex and arthritis models","pmids":["31211699"],"confidence":"High","gaps":["Downstream neuronal signaling and ion-channel coupling undefined","Whether γ-chain participates in neurons not addressed"]},{"year":2019,"claim":"Showed that Fcγ RI-mediated IgG sequestration in immune cells drives hepatic off-target uptake of radioimmunoconjugates, a pharmacological consequence of high-affinity Fc binding.","evidence":"SPR, ELISA, flow cytometry, and PET biodistribution of glycosylated vs deglycosylated conjugates in athymic, NSG, and humanized NSG mice","pmids":["30733320"],"confidence":"High","gaps":["Cellular site of hepatic sequestration not fully resolved","Relevance to fully human contexts inferred from humanized mice"]},{"year":2021,"claim":"Demonstrated that Fcγ RI expression dramatically potentiates antibody neutralization of HIV-1, indicating a role for the receptor in antiviral antibody function.","evidence":"Neutralization assays in TZM-bl cells with/without Fcγ RI, tier-1/tier-2 virus comparison, and guinea pig immune sera with Fcγ RI-blocking controls","pmids":["33431684"],"confidence":"Medium","gaps":["Mechanism of potentiation (capture vs signaling) not dissected","Single lab, cell-based"]},{"year":2022,"claim":"Linked FCGR1A genetic variation to CD64 expression and effector function, providing human genetic evidence for functional modulation.","evidence":"Promoter reporter assays and genotype-phenotype association plus phagocytosis/degranulation/cytokine assays for the p.D324N coding variant","pmids":["35371020"],"confidence":"Medium","gaps":["Mechanism by which p.D324N alters function not defined","Variant effects on clinical phenotypes not established"]},{"year":2023,"claim":"Separated the IgG-capture function from intracellular signaling and extended neuronal Fcγ RI to neuropathic pain, clarifying both engineering applications and pain mechanisms.","evidence":"Full-length vs intracellularly truncated CD64 overexpression in iPSC-derived cells with ADCC/CDC and humanized mouse models; DRG-neuron-specific Fcgr1 conditional knockout with CRP/IgG microinjection and pain behavior","pmids":["36593395","36727833"],"confidence":"High","gaps":["Neuronal Fcγ RI signaling effectors not fully mapped","Whether neuronal CRP signaling uses the γ-chain unresolved"]},{"year":2025,"claim":"Showed therapeutic antibody Fc engagement of CD64 can mediate cytokine capture and internalization, demonstrating an Fc-CD64 axis exploitable for drug potency.","evidence":"Flow cytometry, live-cell confocal imaging of IL-23 internalization, and CD64+ THP-1 co-culture reporter assays with Fc-blocking controls (guselkumab vs risankizumab)","pmids":["40145093"],"confidence":"Medium","gaps":["In vitro only; in vivo relevance untested","Single lab"]},{"year":null,"claim":"How the α-chain cytoplasmic tail, serine phosphorylation, periplakin, and the γ-chain ITAM are mechanistically integrated to specify divergent outcomes (phagocytosis vs antigen routing vs cytokine programs vs neuronal pain) remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified signaling model connecting tail phosphorylation to PLD1/SK1 and inflammasome outputs","Neuronal Fcγ RI downstream effectors and γ-chain dependence undefined","Structural basis of nanocluster scaffolding and SIRPα tethering unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0001618","term_label":"virus receptor activity","supporting_discovery_ids":[15,30]},{"term_id":"GO:0038024","term_label":"cargo receptor activity","supporting_discovery_ids":[4,9,32]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,2,19]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[11,12]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[11,17,26]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[4,19]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[8,9,19]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[4,5,25]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[19,22,26]}],"complexes":["Fcγ RI α-chain / FcR γ-chain complex"],"partners":["FCER1G","FCGR2A","PPL","SIRPA","CRP","SYK","LILRB4"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P12314","full_name":"High affinity immunoglobulin gamma Fc receptor I","aliases":["Fc-gamma RI","FcRI","Fc-gamma RIA","FcgammaRIa"],"length_aa":374,"mass_kda":42.6,"function":"High affinity receptor for the Fc region of immunoglobulins gamma. Functions in both innate and adaptive immune responses. Mediates IgG effector functions on monocytes triggering antibody-dependent cellular cytotoxicity (ADCC) of virus-infected cells","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P12314/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/FCGR1A","classification":"Common Essential","n_dependent_lines":316,"n_total_lines":380,"dependency_fraction":0.8315789473684211},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/FCGR1A","total_profiled":1310},"omim":[{"mim_id":"615978","title":"IMMUNODEFICIENCY 27B; IMD27B","url":"https://www.omim.org/entry/615978"},{"mim_id":"613562","title":"Fc RECEPTOR-LIKE PROTEIN 6; FCRL6","url":"https://www.omim.org/entry/613562"},{"mim_id":"611775","title":"KAWASAKI DISEASE","url":"https://www.omim.org/entry/611775"},{"mim_id":"606891","title":"Fc RECEPTOR-LIKE PROTEIN A; FCRLA","url":"https://www.omim.org/entry/606891"},{"mim_id":"606510","title":"Fc RECEPTOR-LIKE PROTEIN 3; FCRL3","url":"https://www.omim.org/entry/606510"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Vesicles","reliability":"Uncertain"},{"location":"Golgi apparatus","reliability":"Additional"},{"location":"Plasma membrane","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"epididymis","ntpm":95.0}],"url":"https://www.proteinatlas.org/search/FCGR1A"},"hgnc":{"alias_symbol":["CD64","CD64A","FcgammaRI","FcgammaRIa","FCG1","FCGR1"],"prev_symbol":[]},"alphafold":{"accession":"P12314","domains":[{"cath_id":"2.60.40.10","chopping":"21-102","consensus_level":"medium","plddt":92.7872,"start":21,"end":102},{"cath_id":"2.60.40.10","chopping":"104-187","consensus_level":"medium","plddt":96.2635,"start":104,"end":187},{"cath_id":"2.60.40.10","chopping":"194-282","consensus_level":"high","plddt":93.2628,"start":194,"end":282}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P12314","model_url":"https://alphafold.ebi.ac.uk/files/AF-P12314-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P12314-F1-predicted_aligned_error_v6.png","plddt_mean":85.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FCGR1A","jax_strain_url":"https://www.jax.org/strain/search?query=FCGR1A"},"sequence":{"accession":"P12314","fasta_url":"https://rest.uniprot.org/uniprotkb/P12314.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P12314/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P12314"}},"corpus_meta":[{"pmid":"11911824","id":"PMC_11911824","title":"FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection.","date":"2002","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/11911824","citation_count":223,"is_preprint":false},{"pmid":"11911823","id":"PMC_11911823","title":"FcgammaRI-deficient mice show multiple alterations to inflammatory and immune responses.","date":"2002","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/11911823","citation_count":155,"is_preprint":false},{"pmid":"20206205","id":"PMC_20206205","title":"Neutrophil CD64 expression as marker of bacterial infection: a systematic review and meta-analysis.","date":"2010","source":"The Journal of infection","url":"https://pubmed.ncbi.nlm.nih.gov/20206205","citation_count":133,"is_preprint":false},{"pmid":"21325219","id":"PMC_21325219","title":"Functional characteristics of the high affinity IgG receptor, FcγRI.","date":"2011","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/21325219","citation_count":131,"is_preprint":false},{"pmid":"19642859","id":"PMC_19642859","title":"Neutrophil CD64: a diagnostic marker for infection and sepsis.","date":"2009","source":"Clinical chemistry and laboratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19642859","citation_count":128,"is_preprint":false},{"pmid":"23293080","id":"PMC_23293080","title":"The high-affinity human IgG receptor FcγRI (CD64) promotes IgG-mediated inflammation, anaphylaxis, and antitumor immunotherapy.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/23293080","citation_count":117,"is_preprint":false},{"pmid":"22940278","id":"PMC_22940278","title":"Neutrophil CD64 expression as a biomarker in the early diagnosis of bacterial infection: a meta-analysis.","date":"2012","source":"International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","url":"https://pubmed.ncbi.nlm.nih.gov/22940278","citation_count":106,"is_preprint":false},{"pmid":"17005690","id":"PMC_17005690","title":"Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fcgamma RIA (CD64) or FcgammaRIIA (CD32).","date":"2006","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/17005690","citation_count":103,"is_preprint":false},{"pmid":"28895912","id":"PMC_28895912","title":"CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory Diseases.","date":"2017","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/28895912","citation_count":103,"is_preprint":false},{"pmid":"19144150","id":"PMC_19144150","title":"Increased expression of FcgammaRI/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus.","date":"2009","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/19144150","citation_count":98,"is_preprint":false},{"pmid":"26059345","id":"PMC_26059345","title":"Neutrophil CD64 expression as a diagnostic marker for sepsis in adult patients: a meta-analysis.","date":"2015","source":"Critical care (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/26059345","citation_count":92,"is_preprint":false},{"pmid":"8847330","id":"PMC_8847330","title":"Adaptation to eccentric exercise: effect on CD64 and CD11b/CD18 expression.","date":"1996","source":"Journal of applied physiology (Bethesda, Md. : 1985)","url":"https://pubmed.ncbi.nlm.nih.gov/8847330","citation_count":75,"is_preprint":false},{"pmid":"10397749","id":"PMC_10397749","title":"The FcgammaRIa (CD64) ligand binding chain triggers major histocompatibility complex class II antigen presentation independently of its associated FcR gamma-chain.","date":"1999","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10397749","citation_count":72,"is_preprint":false},{"pmid":"12383205","id":"PMC_12383205","title":"C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcgammaRI).","date":"2002","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12383205","citation_count":66,"is_preprint":false},{"pmid":"17905303","id":"PMC_17905303","title":"Simultaneous quantitative analysis of FcgammaRI (CD64) expression on neutrophils and monocytes: a new, improved way to detect infections.","date":"2007","source":"Journal of immunological methods","url":"https://pubmed.ncbi.nlm.nih.gov/17905303","citation_count":63,"is_preprint":false},{"pmid":"11071653","id":"PMC_11071653","title":"Therapeutic efficacy of FcgammaRI/CD64-directed bispecific antibodies in B-cell lymphoma.","date":"2000","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/11071653","citation_count":59,"is_preprint":false},{"pmid":"7516890","id":"PMC_7516890","title":"The high affinity Fc gamma receptor (CD64) induces phagocytosis in the absence of its cytoplasmic domain: the gamma subunit of Fc gamma RIIIA imparts phagocytic function to Fc gamma RI.","date":"1994","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/7516890","citation_count":59,"is_preprint":false},{"pmid":"17577814","id":"PMC_17577814","title":"Neutrophil CD64 (FcgammaRI) expression is a specific marker of bacterial infection: a study on the kinetics and the impact of major surgery.","date":"2007","source":"Scandinavian journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/17577814","citation_count":59,"is_preprint":false},{"pmid":"30733320","id":"PMC_30733320","title":"The Impact of FcγRI Binding on Immuno-PET.","date":"2019","source":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30733320","citation_count":55,"is_preprint":false},{"pmid":"22420242","id":"PMC_22420242","title":"Neutrophil CD64 as a sepsis biomarker.","date":"2011","source":"Biochemia medica","url":"https://pubmed.ncbi.nlm.nih.gov/22420242","citation_count":55,"is_preprint":false},{"pmid":"35484408","id":"PMC_35484408","title":"CD66b-CD64dimCD115- cells in the human bone marrow represent neutrophil-committed progenitors.","date":"2022","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35484408","citation_count":55,"is_preprint":false},{"pmid":"17621550","id":"PMC_17621550","title":"Hematological indices, inflammatory markers and neutrophil CD64 expression: comparative trends during experimental human endotoxemia.","date":"2007","source":"Journal of endotoxin research","url":"https://pubmed.ncbi.nlm.nih.gov/17621550","citation_count":53,"is_preprint":false},{"pmid":"9881694","id":"PMC_9881694","title":"The second and third extracellular domains of FcgammaRI (CD64) confer the unique high affinity binding of IgG2a.","date":"1998","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9881694","citation_count":52,"is_preprint":false},{"pmid":"31211699","id":"PMC_31211699","title":"Neuronal FcγRI mediates acute and chronic joint pain.","date":"2019","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/31211699","citation_count":51,"is_preprint":false},{"pmid":"32042334","id":"PMC_32042334","title":"The Influence of Glycans-Specific Bioconjugation on the FcγRI Binding and In vivo Performance of 89Zr-DFO-Pertuzumab.","date":"2020","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/32042334","citation_count":51,"is_preprint":false},{"pmid":"19420354","id":"PMC_19420354","title":"Differential signal transduction, membrane trafficking, and immune effector functions mediated by FcgammaRI versus FcgammaRIIa.","date":"2009","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19420354","citation_count":50,"is_preprint":false},{"pmid":"26497519","id":"PMC_26497519","title":"The many faces of FcγRI: implications for therapeutic antibody function.","date":"2015","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/26497519","citation_count":48,"is_preprint":false},{"pmid":"28289091","id":"PMC_28289091","title":"Membrane nanoclusters of FcγRI segregate from inhibitory SIRPα upon activation of human macrophages.","date":"2017","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/28289091","citation_count":48,"is_preprint":false},{"pmid":"20407370","id":"PMC_20407370","title":"The novel applications of the quantitative analysis of neutrophil cell surface FcgammaRI (CD64) to the diagnosis of infectious and inflammatory diseases.","date":"2010","source":"Current opinion in infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/20407370","citation_count":45,"is_preprint":false},{"pmid":"22493081","id":"PMC_22493081","title":"FcγRI mediates serum amyloid P inhibition of fibrocyte differentiation.","date":"2012","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/22493081","citation_count":44,"is_preprint":false},{"pmid":"39617174","id":"PMC_39617174","title":"An engineered α1β1 integrin-mediated FcγRI signaling component to control enhanced CAR macrophage activation and phagocytosis.","date":"2024","source":"Journal of controlled release : official journal of the Controlled Release Society","url":"https://pubmed.ncbi.nlm.nih.gov/39617174","citation_count":42,"is_preprint":false},{"pmid":"23452299","id":"PMC_23452299","title":"CD64-Neutrophil expression and stress metabolic patterns in early sepsis and severe traumatic brain injury in children.","date":"2013","source":"BMC pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/23452299","citation_count":42,"is_preprint":false},{"pmid":"15229321","id":"PMC_15229321","title":"Direct interaction between FcgammaRI (CD64) and periplakin controls receptor endocytosis and ligand binding capacity.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15229321","citation_count":41,"is_preprint":false},{"pmid":"29668526","id":"PMC_29668526","title":"Immunophenotyping of Monocytes During Human Sepsis Shows Impairment in Antigen Presentation: A Shift Toward Nonclassical Differentiation and Upregulation of FCγRi-Receptor.","date":"2018","source":"Shock (Augusta, Ga.)","url":"https://pubmed.ncbi.nlm.nih.gov/29668526","citation_count":41,"is_preprint":false},{"pmid":"22937039","id":"PMC_22937039","title":"Fc gamma receptor CD64 modulates the inhibitory activity of infliximab.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22937039","citation_count":41,"is_preprint":false},{"pmid":"11358825","id":"PMC_11358825","title":"Enhancement of polymorphonuclear cell-mediated tumor cell killing on simultaneous engagement of fcgammaRI (CD64) and fcalphaRI (CD89).","date":"2001","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/11358825","citation_count":40,"is_preprint":false},{"pmid":"18354234","id":"PMC_18354234","title":"Destructive arthritis in the absence of both FcgammaRI and FcgammaRIII.","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18354234","citation_count":39,"is_preprint":false},{"pmid":"36593395","id":"PMC_36593395","title":"Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression.","date":"2023","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/36593395","citation_count":37,"is_preprint":false},{"pmid":"26497521","id":"PMC_26497521","title":"Structural mechanism of high affinity FcγRI recognition of immunoglobulin G.","date":"2015","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/26497521","citation_count":36,"is_preprint":false},{"pmid":"21124939","id":"PMC_21124939","title":"Fcγ receptor I alpha chain (CD64) expression in macrophages is critical for the onset of meningitis by Escherichia coli K1.","date":"2010","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/21124939","citation_count":36,"is_preprint":false},{"pmid":"11092616","id":"PMC_11092616","title":"Production of macrophage-activated killer cells for targeting of glioblastoma cells with bispecific antibody to FcgammaRI and the epidermal growth factor receptor.","date":"2000","source":"Cancer immunology, immunotherapy : CII","url":"https://pubmed.ncbi.nlm.nih.gov/11092616","citation_count":36,"is_preprint":false},{"pmid":"29920250","id":"PMC_29920250","title":"FcγRI (CD64) contributes to the severity of immune inflammation through regulating NF-κB/NLRP3 inflammasome pathway.","date":"2018","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29920250","citation_count":34,"is_preprint":false},{"pmid":"15868620","id":"PMC_15868620","title":"Neutrophil CD64 expression in Behçet's disease.","date":"2005","source":"The Journal of rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/15868620","citation_count":34,"is_preprint":false},{"pmid":"15075346","id":"PMC_15075346","title":"FcgammaRIIa expression with FcgammaRI results in C-reactive protein- and IgG-mediated phagocytosis.","date":"2004","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/15075346","citation_count":32,"is_preprint":false},{"pmid":"30042128","id":"PMC_30042128","title":"Mechanisms of inside-out signaling of the high-affinity IgG receptor FcγRI.","date":"2018","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/30042128","citation_count":31,"is_preprint":false},{"pmid":"20109752","id":"PMC_20109752","title":"Targeting allergen to FcgammaRI reveals a novel T(H)2 regulatory pathway linked to thymic stromal lymphopoietin receptor.","date":"2010","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/20109752","citation_count":31,"is_preprint":false},{"pmid":"28898742","id":"PMC_28898742","title":"Neutrophil CD64, C-reactive protein, and procalcitonin in the identification of sepsis in the ICU - Post-test probabilities.","date":"2017","source":"Journal of critical care","url":"https://pubmed.ncbi.nlm.nih.gov/28898742","citation_count":31,"is_preprint":false},{"pmid":"32076472","id":"PMC_32076472","title":"Effect of neutrophil CD64 for diagnosing sepsis in emergency department.","date":"2020","source":"World journal of emergency medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32076472","citation_count":30,"is_preprint":false},{"pmid":"18207250","id":"PMC_18207250","title":"FcgammaRI (CD64) resides constitutively in lipid rafts.","date":"2008","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/18207250","citation_count":29,"is_preprint":false},{"pmid":"30262053","id":"PMC_30262053","title":"Combined CD25, CD64, and CD69 biomarker panel for flow cytometry diagnosis of sepsis.","date":"2018","source":"Talanta","url":"https://pubmed.ncbi.nlm.nih.gov/30262053","citation_count":29,"is_preprint":false},{"pmid":"10233728","id":"PMC_10233728","title":"Differentiation-dependent switch in protein kinase C isoenzyme activation by FcgammaRI, the human high-affinity receptor for immunoglobulin G.","date":"1999","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10233728","citation_count":28,"is_preprint":false},{"pmid":"27565453","id":"PMC_27565453","title":"Neutrophil CD64 expression as a longitudinal biomarker for severe disease and acute infection in critically ill patients.","date":"2016","source":"International journal of laboratory hematology","url":"https://pubmed.ncbi.nlm.nih.gov/27565453","citation_count":28,"is_preprint":false},{"pmid":"27268050","id":"PMC_27268050","title":"Meta-analysis of diagnostic accuracy of neutrophil CD64 for neonatal sepsis.","date":"2016","source":"Italian journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/27268050","citation_count":27,"is_preprint":false},{"pmid":"18097060","id":"PMC_18097060","title":"Targeting immune complex-mediated hypersensitivity with recombinant soluble human FcgammaRIA (CD64A).","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18097060","citation_count":26,"is_preprint":false},{"pmid":"19454724","id":"PMC_19454724","title":"Recombinant soluble human FcgammaR1A (CD64A) reduces inflammation in murine collagen-induced arthritis.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19454724","citation_count":26,"is_preprint":false},{"pmid":"10514529","id":"PMC_10514529","title":"The cytoplasmic domain of human FcgammaRIa alters the functional properties of the FcgammaRI.gamma-chain receptor complex.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10514529","citation_count":26,"is_preprint":false},{"pmid":"16028647","id":"PMC_16028647","title":"CD64 (Fcgamma receptor I) cell surface expression on maturing neutrophils from preterm and term newborn infants.","date":"2005","source":"Acta paediatrica (Oslo, Norway : 1992)","url":"https://pubmed.ncbi.nlm.nih.gov/16028647","citation_count":26,"is_preprint":false},{"pmid":"15539412","id":"PMC_15539412","title":"Depletion of synovial macrophages in rheumatoid arthritis by an anti-FcgammaRI-calicheamicin immunoconjugate.","date":"2004","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/15539412","citation_count":26,"is_preprint":false},{"pmid":"21185301","id":"PMC_21185301","title":"Identification of IgG(1) variants with increased affinity to FcγRIIIa and unaltered affinity to FcγRI and FcRn: comparison of soluble receptor-based and cell-based binding assays.","date":"2010","source":"Journal of immunological methods","url":"https://pubmed.ncbi.nlm.nih.gov/21185301","citation_count":26,"is_preprint":false},{"pmid":"31094395","id":"PMC_31094395","title":"Smartphone-imaged microfluidic biochip for measuring CD64 expression from whole blood.","date":"2019","source":"The Analyst","url":"https://pubmed.ncbi.nlm.nih.gov/31094395","citation_count":26,"is_preprint":false},{"pmid":"40145093","id":"PMC_40145093","title":"Guselkumab binding to CD64+ IL-23-producing myeloid cells enhances potency for neutralizing IL-23 signaling.","date":"2025","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/40145093","citation_count":25,"is_preprint":false},{"pmid":"36284837","id":"PMC_36284837","title":"Targeting the high affinity receptor, FcγRI, in autoimmune disease, neuropathy, and cancer.","date":"2022","source":"Immunotherapy advances","url":"https://pubmed.ncbi.nlm.nih.gov/36284837","citation_count":25,"is_preprint":false},{"pmid":"27725776","id":"PMC_27725776","title":"Leukocyte immunoglobulin-like receptor B4 regulates key signalling molecules involved in FcγRI-mediated clathrin-dependent endocytosis and phagocytosis.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27725776","citation_count":25,"is_preprint":false},{"pmid":"10519993","id":"PMC_10519993","title":"Role of FcgammaRI (CD64) in erythrocyte elimination and its up-regulation in thalassaemia.","date":"1999","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/10519993","citation_count":23,"is_preprint":false},{"pmid":"15161926","id":"PMC_15161926","title":"Modulation of FcgammaRI (CD64) ligand binding by blocking peptides of periplakin.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15161926","citation_count":23,"is_preprint":false},{"pmid":"30190171","id":"PMC_30190171","title":"Lentivirus-mediated knockdown of FcγRI (CD64) attenuated lupus nephritis via inhibition of NF-κB regulating NLRP3 inflammasome activation in MRL/lpr mice.","date":"2018","source":"Journal of pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30190171","citation_count":23,"is_preprint":false},{"pmid":"9335317","id":"PMC_9335317","title":"Humanized mAb H22 binds the human high affinity Fc receptor for IgG (FcgammaRI), blocks phagocytosis, and modulates receptor expression.","date":"1997","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/9335317","citation_count":23,"is_preprint":false},{"pmid":"27556927","id":"PMC_27556927","title":"Expression of CD64 on Circulating Neutrophils Favoring Systemic Inflammatory Status in Erythema Nodosum Leprosum.","date":"2016","source":"PLoS neglected tropical diseases","url":"https://pubmed.ncbi.nlm.nih.gov/27556927","citation_count":23,"is_preprint":false},{"pmid":"25866876","id":"PMC_25866876","title":"Kinetics of leukocyte CD11b and CD64 expression in severe sepsis and non-infectious critical care patients.","date":"2015","source":"Acta anaesthesiologica Scandinavica","url":"https://pubmed.ncbi.nlm.nih.gov/25866876","citation_count":23,"is_preprint":false},{"pmid":"16308225","id":"PMC_16308225","title":"Cell surface expression of FcgammaRI (CD64) on neutrophils and monocytes in patients with influenza A, with and without complications.","date":"2005","source":"Scandinavian journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/16308225","citation_count":21,"is_preprint":false},{"pmid":"23757034","id":"PMC_23757034","title":"Are neutrophil CD64 expression and interleukin-6 early useful markers for diagnosis of acute appendicitis?","date":"2013","source":"European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie","url":"https://pubmed.ncbi.nlm.nih.gov/23757034","citation_count":21,"is_preprint":false},{"pmid":"34377464","id":"PMC_34377464","title":"High expression of neutrophil and monocyte CD64 with simultaneous lack of upregulation of adhesion receptors CD11b, CD162, CD15, CD65 on neutrophils in severe COVID-19.","date":"2021","source":"Therapeutic advances in infectious disease","url":"https://pubmed.ncbi.nlm.nih.gov/34377464","citation_count":21,"is_preprint":false},{"pmid":"33431684","id":"PMC_33431684","title":"The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/33431684","citation_count":21,"is_preprint":false},{"pmid":"36727833","id":"PMC_36727833","title":"Neuronal C-Reactive Protein/FcγRI Positive Feedback Proinflammatory Signaling Contributes to Nerve Injury Induced Neuropathic Pain.","date":"2023","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/36727833","citation_count":20,"is_preprint":false},{"pmid":"30029898","id":"PMC_30029898","title":"Neutrophil CD64, TLR2 and TLR4 expression increases but phagocytic potential decreases during tuberculosis.","date":"2018","source":"Tuberculosis (Edinburgh, Scotland)","url":"https://pubmed.ncbi.nlm.nih.gov/30029898","citation_count":20,"is_preprint":false},{"pmid":"17827066","id":"PMC_17827066","title":"Hyperexpression of FcgammaRI and Toll-like receptor 4 in the intestinal mast cells of Crohn's disease patients.","date":"2007","source":"Clinical immunology (Orlando, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/17827066","citation_count":20,"is_preprint":false},{"pmid":"12200451","id":"PMC_12200451","title":"The CY domain of the Fcgamma RIa alpha-chain (CD64) alters gamma-chain tyrosine-based signaling and phagocytosis.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12200451","citation_count":20,"is_preprint":false},{"pmid":"16912901","id":"PMC_16912901","title":"Molecular cloning and expression of the porcine high-affinity immunoglobulin G Fc receptor (FcgammaRI).","date":"2006","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/16912901","citation_count":20,"is_preprint":false},{"pmid":"17255341","id":"PMC_17255341","title":"Affinity of C-reactive protein toward FcgammaRI is strongly enhanced by the gamma-chain.","date":"2007","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/17255341","citation_count":20,"is_preprint":false},{"pmid":"31085013","id":"PMC_31085013","title":"Diagnostic value of neutrophil CD64 combined with CRP for neonatal sepsis: A meta-analysis.","date":"2019","source":"The American journal of emergency medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31085013","citation_count":20,"is_preprint":false},{"pmid":"23867450","id":"PMC_23867450","title":"Diagnostic accuracy of neutrophil CD64 expression in neonatal infection: a meta-analysis.","date":"2013","source":"The Journal of international medical research","url":"https://pubmed.ncbi.nlm.nih.gov/23867450","citation_count":19,"is_preprint":false},{"pmid":"21070860","id":"PMC_21070860","title":"Brucella abortus inhibits IFN-γ-induced FcγRI expression and FcγRI-restricted phagocytosis via toll-like receptor 2 on human monocytes/macrophages.","date":"2010","source":"Microbes and infection","url":"https://pubmed.ncbi.nlm.nih.gov/21070860","citation_count":19,"is_preprint":false},{"pmid":"30273630","id":"PMC_30273630","title":"The alternatively spliced porcine FcγRI regulated PRRSV-ADE infection and proinflammatory cytokine production.","date":"2018","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30273630","citation_count":18,"is_preprint":false},{"pmid":"10405359","id":"PMC_10405359","title":"Influence of the human high-affinity IgG receptor FcgammaRI (CD64) on residual infectivity of neutralized dengue virus.","date":"1999","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/10405359","citation_count":18,"is_preprint":false},{"pmid":"29540108","id":"PMC_29540108","title":"Neutrophil CD64 expression, procalcitonin and presepsin are useful to differentiate infections from flares in SLE patients with SIRS.","date":"2018","source":"Lupus","url":"https://pubmed.ncbi.nlm.nih.gov/29540108","citation_count":18,"is_preprint":false},{"pmid":"38332201","id":"PMC_38332201","title":"Crosstalk between CD64+MHCII+ macrophages and CD4+ T cells drives joint pathology during chikungunya.","date":"2024","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38332201","citation_count":17,"is_preprint":false},{"pmid":"35371020","id":"PMC_35371020","title":"Novel Human FCGR1A Variants Affect CD64 Functions and Are Risk Factors for Sarcoidosis.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35371020","citation_count":16,"is_preprint":false},{"pmid":"32890312","id":"PMC_32890312","title":"Evaluating the Timeliness and Specificity of CD69, CD64, and CD25 as Biomarkers of Sepsis in Mice.","date":"2021","source":"Shock (Augusta, Ga.)","url":"https://pubmed.ncbi.nlm.nih.gov/32890312","citation_count":16,"is_preprint":false},{"pmid":"35281028","id":"PMC_35281028","title":"Examination of IgG Fc Receptor CD16A and CD64 Expression by Canine Leukocytes and Their ADCC Activity in Engineered NK Cells.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35281028","citation_count":16,"is_preprint":false},{"pmid":"11420747","id":"PMC_11420747","title":"Tumor cells express FcgammaRI which contributes to tumor cell growth and a metastatic phenotype.","date":"2001","source":"Neoplasia (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11420747","citation_count":16,"is_preprint":false},{"pmid":"36716100","id":"PMC_36716100","title":"Development of an Aptamer-Based Molecular Tool for Specifically Targeting Microglia via the CD64 Protein.","date":"2023","source":"Analytical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36716100","citation_count":16,"is_preprint":false},{"pmid":"18279703","id":"PMC_18279703","title":"Expression of CD64, CD206, and RAGE in adherent cells of diabetic patients infected with Mycobacterium tuberculosis.","date":"2008","source":"Archives of medical research","url":"https://pubmed.ncbi.nlm.nih.gov/18279703","citation_count":16,"is_preprint":false},{"pmid":"10752630","id":"PMC_10752630","title":"Mouse FcgammaRI: identification and functional characterization of five new alleles.","date":"2000","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/10752630","citation_count":16,"is_preprint":false},{"pmid":"26497520","id":"PMC_26497520","title":"The high-affinity receptor for IgG, FcγRI, of humans and non-human primates.","date":"2015","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/26497520","citation_count":15,"is_preprint":false},{"pmid":"19689341","id":"PMC_19689341","title":"Fcgamma receptor 1 (CD64), a target beyond cancer.","date":"2009","source":"Current pharmaceutical design","url":"https://pubmed.ncbi.nlm.nih.gov/19689341","citation_count":15,"is_preprint":false},{"pmid":"15136586","id":"PMC_15136586","title":"The monocyte Fcgamma receptors FcgammaRI/gamma and FcgammaRIIA differ in their interaction with Syk and with Src-related tyrosine kinases.","date":"2004","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/15136586","citation_count":15,"is_preprint":false},{"pmid":"29352854","id":"PMC_29352854","title":"Fc gamma receptor binding profile of anti-citrullinated protein antibodies in immune complexes suggests a role for FcγRI in the pathogenesis of synovial inflammation.","date":"2018","source":"Clinical and experimental rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/29352854","citation_count":15,"is_preprint":false},{"pmid":"39187291","id":"PMC_39187291","title":"CD64+ fibroblast-targeted vilanterol and a STING agonist augment CLDN18.2 BiTEs efficacy against pancreatic cancer by reducing desmoplasia and enriching stem-like CD8+ T cells.","date":"2024","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/39187291","citation_count":14,"is_preprint":false},{"pmid":"9737671","id":"PMC_9737671","title":"FcgammaRIa-gamma-chain complexes trigger antibody-dependent cell-mediated cytotoxicity (ADCC) in CD5+ B cell/macrophage IIA1.6 cells.","date":"1998","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9737671","citation_count":14,"is_preprint":false},{"pmid":"8663283","id":"PMC_8663283","title":"Extracellular mutations of non-obese diabetic mouse FcgammaRI modify surface expression and ligand binding.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8663283","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52081,"output_tokens":10478,"usd":0.156706,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":21953,"output_tokens":7068,"usd":0.143233,"stage2_stop_reason":"end_turn"},"total_usd":0.299939,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"FcγRI (CD64) does not require its own cytoplasmic domain to mediate phagocytosis; instead, the γ-subunit of FcγRIIIA confers phagocytic function to FcγRI. Coexpression of FcγRI with the FcγRIIIA γ-subunit in COS-1 cells conferred phagocytic capability even to a cytoplasmic-domain-deleted mutant of FcγRI, demonstrating that the γ-subunit ITAM, not the FcγRI cytoplasmic tail, drives the phagocytic signal.\",\n      \"method\": \"COS-1 cell transfection with wild-type and cytoplasmic-domain-deletion mutants of FcγRI; co-transfection with γ-subunit of FcγRIIIA; IgG-coated red blood cell phagocytosis assay; tyrosine kinase inhibitor (tyrphostin 23) studies\",\n      \"journal\": \"Experimental hematology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution in transfected cells with domain-deletion mutagenesis and orthogonal inhibitor experiments, directly mapping phagocytic signal to γ-subunit ITAM\",\n      \"pmids\": [\"7516890\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Extracellular domain mutations in the NOD mouse FcγRI increase IgG affinity ~10-fold (via a profoundly reduced dissociation rate) while reducing surface expression to one-tenth of wild-type. The expression level differences map to the extracellular region, and mouse FcγRI can associate with the FcεRI γ-subunit analogously to human FcγRI.\",\n      \"method\": \"Kinetic binding analysis (association/dissociation rates) of NOD vs BALB/c FcγRI; COS-7 transfection with chimeric extracellular domain swaps; co-transfection with FcεRI γ-subunit\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (kinetics, mutagenesis, domain-swap chimeras) in a single rigorous study\",\n      \"pmids\": [\"8663283\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"FcγRIa-γ-chain complexes expressed in IIA1.6 cells trigger both phagocytosis and ADCC, and an intact ITAM in either the FcR γ-chain or FcγRIIa is essential for triggering these biological functions via the FcγRIa complex.\",\n      \"method\": \"Transfection of FcγRIa and γ-chain constructs into IIA1.6 cells; ITAM mutagenesis; phagocytosis of Staphylococcus aureus; ADCC of erythrocytes\",\n      \"journal\": \"Clinical and experimental immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — ITAM mutagenesis combined with two functional assays (phagocytosis and ADCC) in a reconstitution system\",\n      \"pmids\": [\"9737671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The unique high-affinity IgG2a binding of FcγRI (CD64) is conferred by the specific interaction between extracellular domains 2 and 3; domain 1 plays a supporting role in conformational stability. Replacement of domains 2 and 3 of FcγRII with those of FcγRI reconstitutes specific high-affinity monomeric IgG2a binding.\",\n      \"method\": \"Domain-swap chimeric receptors generated between mouse FcγRI and mouse FcγRII; IgG binding studies with monomeric IgG2a, IgG1, and IgG2b\",\n      \"journal\": \"Molecular immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic domain-swap mutagenesis with direct IgG binding measurements identifying the structural basis of high-affinity binding\",\n      \"pmids\": [\"9881694\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The FcγRIa α-chain cytoplasmic tail contains autonomous targeting information directing internalized receptor-antigen complexes to MHC class II-containing late endosomes for antigen presentation, independently of the FcR γ-chain ITAM. Deletion of the cytoplasmic tail diverts complexes to the recycling pathway and decreases antigen presentation, demonstrating a functional role for the tail distinct from canonical tyrosine/dileucine motifs.\",\n      \"method\": \"IIA1.6 cell transfection with FcγRIa constructs (wild-type, ITAM-mutant γ-chain, cytoplasmic-tail deletion); immunoelectron microscopy tracking receptor-ligand complex trafficking; MHC class II antigen presentation assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — immunoelectron microscopy plus domain-deletion mutagenesis plus functional antigen-presentation readout in a single study\",\n      \"pmids\": [\"10397749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The cytoplasmic domain (CY) of FcγRIa α-chain directly modulates the functional properties of the receptor complex: CY deletion slows kinetics of receptor-specific phagocytosis and endocytosis, converts calcium-independent phagocytosis to calcium-dependent phagocytosis, and abrogates FcγRIa-specific IL-6 secretion without affecting IL-1β production.\",\n      \"method\": \"Stable transfectants in murine macrophages expressing full-length or CY-deletion mutant FcγRIa; IgG-opsonized particle phagocytosis assay; calcium measurement; cytokine ELISA\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — domain-deletion mutagenesis with multiple orthogonal functional readouts (kinetics, calcium dependency, cytokine output)\",\n      \"pmids\": [\"10514529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"FcγRI aggregation in IFN-γ-primed U937 cells activates the novel PKC isoenzymes δ, ε, and atypical PKC ζ (calcium-independent), whereas in cells differentiated to a macrophage phenotype it activates conventional calcium-dependent PKCs α, β, and γ, consistent with differentiation-state-dependent coupling to distinct phospholipase pathways.\",\n      \"method\": \"PKC activity assays and translocation studies in IFN-γ-primed vs dbcAMP-differentiated U937 cells after FcγRI aggregation; isoenzyme-specific fractionation\",\n      \"journal\": \"Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-based functional assays with isoenzyme fractionation, single lab, two differentiation states\",\n      \"pmids\": [\"10233728\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The serine residues in the FcγRIa α-chain cytoplasmic domain are constitutively phosphorylated and this phosphorylation regulates early tyrosine-phosphorylation cascades and phagocytosis; mutation of cytoplasmic serine residues to alanine abolishes okadaic acid (phosphatase inhibitor) inhibition of phagocytosis, while cytoplasmic domain truncation and serine mutations have distinct effects on cytokine production vs. phagocytosis.\",\n      \"method\": \"FcγRIa molecular variants (serine→alanine mutants, truncation mutants) expressed in murine macrophage P388D1 cells; okadaic acid treatment; phagocytosis assay; tyrosine phosphorylation immunoblot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic mutagenesis of the cytoplasmic domain with multiple functional and biochemical readouts establishing serine phosphorylation as a regulatory mechanism\",\n      \"pmids\": [\"12200451\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"FcγRI is required for IgG2a immune complex-induced phagocytosis, cytokine release, cellular cytotoxicity, and antigen presentation in vivo; FcγRI-deficient mice show impaired hypersensitivity responses, reduced cartilage destruction in arthritis, and impaired protection from bacterial infection.\",\n      \"method\": \"FcγRI knockout mouse studies across multiple in vivo models (hypersensitivity, collagen-induced arthritis, bacterial infection); comparison with FcγRIII-KO and complement-deficient mice\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function in multiple disease models with specific cellular and immunological phenotypes, replicated across independent labs (two papers same year)\",\n      \"pmids\": [\"11911824\", \"11911823\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"FcγRI is the primary mediator of endocytosis of monomeric IgG; in its absence, kinetics and extent of immune complex phagocytosis are impaired, macrophage-based ADCC is impaired, and immune complex-dependent antigen presentation to T cells is reduced. FcγRI-deficient mice also show elevated antibody responses, implying FcγRI acts as a control point for antibody production. Additionally, FcR-γ-chain-deficient mice express a partially functional FcγRI.\",\n      \"method\": \"FcγRI knockout mouse generation (gene targeting); in vitro phagocytosis, ADCC, and antigen-presentation assays; in vivo antibody response measurements\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with multiple orthogonal functional readouts, independent replication\",\n      \"pmids\": [\"11911823\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"C-reactive protein (CRP) binds directly to the extracellular portion of FcγRI with approximately 3-fold higher affinity than IgG (KD ≈ 0.81 nM) in a calcium-dependent manner. CRP opsonization of phosphorylcholine-coated erythrocytes induces phagocytosis via FcγRI/γ-chain transfectants and activates phospholipase D in IFN-γ-treated U937 cells, indicating CRP can crosslink FcγRI to trigger signaling.\",\n      \"method\": \"BIAcore surface plasmon resonance for binding kinetics; COS-7 transfection with FcγRI chimeras; phagocytosis assay; phospholipase D activation in U937 cells; IgG1 competition and calcium chelation experiments\",\n      \"journal\": \"Immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct binding kinetics plus functional phagocytosis and signaling assays in a single study, single lab\",\n      \"pmids\": [\"12383205\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Periplakin (PPL) selectively interacts with the intracellular cytoplasmic tail of the FcγRI α-chain (but not other activatory FcRs). This interaction controls FcγRI ligand binding capacity, endocytosis, and antigen presentation; PPL and FcγRI co-localize at the plasma membrane of monocytes, and both are upregulated by IFN-γ.\",\n      \"method\": \"Co-immunoprecipitation; blot-overlay assay; confocal co-localization in monocytes and transfectants; overexpression of C-terminal PPL to assess FcγRI functional outcomes (ligand binding, endocytosis, antigen presentation)\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, blot-overlay, co-localization, and multiple functional readouts confirming the interaction and its consequence\",\n      \"pmids\": [\"15229321\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"TAT-peptides that block FcγRI–periplakin interaction modulate FcγRI ligand-binding capacity (assessed by erythrocyte-antibody rosetting), demonstrating a dominant-negative role for C-terminal periplakin in FcγRI biological activity. Alanine-substitution mapping of the FcγRI cytoplasmic tail and random mutagenesis of periplakin defined the specific interaction domains.\",\n      \"method\": \"Truncated and alanine-substituted FcγRI mutants; randomly mutagenized periplakin; TAT-peptide blocking of endogenous FcγRI–periplakin interaction; erythrocyte-antibody rosetting assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic mutagenesis of both binding partners with cell-permeant peptide interference and functional readout, single lab\",\n      \"pmids\": [\"15161926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"FcγRI can use FcγRIIa (R131 or H131 allele) to phagocytose IgG- or CRP-opsonized erythrocytes in the absence of the FcR γ-chain; this phagocytosis requires the cytoplasmic ITAM of FcγRIIa (mutation of Y205 or cytoplasmic truncation abrogates phagocytosis). COS-7 cells expressing FcγRI or FcγRIIa alone do not phagocytose.\",\n      \"method\": \"COS-7 transfection with FcγRI alone, FcγRIIa alone, or co-transfection; ITAM-mutant FcγRIIa (Y205 mutation and cytoplasmic truncation); erythrocyte phagocytosis assay; CRP and IgG opsonization\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution in transfected cells with ITAM mutagenesis and two opsonin conditions, mapping phagocytic requirement to FcγRIIa ITAM\",\n      \"pmids\": [\"15075346\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"FcγRI and FcγRIIa differ in their interaction with Syk kinase: FcγRIIA interacts more readily with Syk than the FcγRI/γ-chain complex, contributing to greater phagocytic efficiency of FcγRIIA. Individual Src-related tyrosine kinases (Hck, Lyn) differentially affect phagocytosis and Syk interaction for each receptor.\",\n      \"method\": \"COS-1 cell transfection with FcγRI-γ-γ chimera vs FcγRIIA; co-IP with Syk, Hck, and Lyn; phagocytosis assay with IgG-coated red blood cells\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-immunoprecipitation plus functional phagocytosis readout; single lab\",\n      \"pmids\": [\"15136586\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"FcγRIA (CD64)-mediated enhancement of dengue virus immune complex infectivity requires signaling competency (intact ITAM) in the accessory γ-chain; abrogation of FcγRIA signaling (by expression without γ-chain or coexpression with ITAM-mutant γ-chain) significantly impairs both phagocytosis and dengue virus immune complex infectivity. This contrasts with FcγRIIA where signaling abrogation impairs phagocytosis but not dengue immune complex infectivity.\",\n      \"method\": \"ITAM tyrosine mutagenesis by site-directed mutagenesis; COS-7 transfection with native and signaling-incompetent FcγRIA/FcγRIIA; dengue virus replication measured by plaque assay and flow cytometry\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — site-directed ITAM mutagenesis in reconstituted system with two independent readouts (phagocytosis and viral replication), comparison of two receptor types\",\n      \"pmids\": [\"17005690\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"C-reactive protein binds to FcγRI on intact cells with KD ~10 µM; co-expression of the γ-chain markedly increases CRP affinity to FcγRI (~30-fold enhanced association rate, KD ~0.35 µM), suggesting the γ-chain mediates critical transmembrane interactions that enhance CRP binding to FcγRI. Dissociation of CRP from cell surfaces is extremely slow, indicating multivalent binding and receptor clustering.\",\n      \"method\": \"Ultrasensitive confocal imaging analysis (single-molecule); COS-7 transfection with FcγRI alone or FcγRI+γ-chain; binding kinetics measurement\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — quantitative single-molecule binding kinetics in transfected cells comparing two receptor configurations, single lab\",\n      \"pmids\": [\"17255341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"FcγRI (CD64) constitutively resides within lipid raft microdomains (detergent-insoluble buoyant membranes) together with FcR γ-chain, independent of crosslinking ligand. Cholesterol depletion modulates FcγRI-ligand interactions, and FcγRI co-patches with GM1 glycolipid by confocal imaging.\",\n      \"method\": \"Detergent-insoluble membrane fractionation; confocal co-patching with GM1; cholesterol depletion experiments; ligand-binding assay after cholesterol depletion\",\n      \"journal\": \"Immunology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical fractionation with confocal imaging and functional consequence (ligand binding) upon cholesterol depletion; single lab\",\n      \"pmids\": [\"18207250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Recombinant soluble human FcγRIA (CD64A) binds IgG with high affinity (KD = 1.7×10⁻¹⁰ M), blocks immune complex precipitation, inhibits complement-mediated lysis of antibody-sensitized RBCs, and suppresses immune complex-mediated IL-6, IL-13, MCP-1, and TNF-α production by mast cells. Local or systemic delivery of soluble FcγRIA reduces edema and neutrophil infiltration in the Arthus reaction and prevents joint damage in collagen antibody-induced arthritis in mice.\",\n      \"method\": \"Surface plasmon resonance for binding kinetics; in vitro mast cell cytokine assay; murine Arthus reaction model; collagen antibody-induced arthritis model; 125I-radiolabeling for pharmacokinetics\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct binding kinetics plus multiple in vitro and in vivo functional assays demonstrating the decoy mechanism of soluble FcγRIA\",\n      \"pmids\": [\"18097060\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"FcγRI activation triggers a novel signaling cascade linking phospholipase D1 to sphingosine kinase-1 in U937 cells and primary human monocytes, inducing proinflammatory mediator expression and trafficking of immune complexes into HLA-DM-positive antigen-processing compartments with improved MHC class II antigen presentation. This pathway is distinct from FcγRIIA signaling (which uses phospholipase Cγ1 and induces oxidative burst).\",\n      \"method\": \"Pharmacological inhibitor studies (PLD1, SK1); subcellular trafficking analysis with HLA-DM compartment co-localization; cytokine measurement; MHC class II antigen presentation assay; comparison between FcγRI and FcγRIIA activation\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal signaling readouts (PLD1→SK1 pathway, trafficking, antigen presentation, cytokine) with direct pathway comparison using primary human cells and cell lines\",\n      \"pmids\": [\"19420354\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The FcγRI α-chain (CD64) interacts with OmpA of E. coli K1 independently of IgG opsonization; this interaction requires the full-length α-chain cytoplasmic domain (C-terminal truncation prevents E. coli entry). OmpA binding to FcγRIa prevents γ-chain recruitment and induces a different tyrosine phosphorylation pattern compared with IgG2a-induced phosphorylation. FcγRIa-deficient mice are resistant to E. coli K1 meningitis with accelerated bacterial clearance and increased CR3 expression on macrophages.\",\n      \"method\": \"FcγRIa(-/-) mouse model; overexpression of full-length and C-terminal truncated FcγRIa in COS-1 cells; adoptive macrophage transfer; co-IP to assess γ-chain recruitment; tyrosine phosphorylation immunoblot; CR3 expression flow cytometry\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO plus domain mutagenesis plus multiple mechanistic readouts (γ-chain recruitment, phosphorylation pattern, adoptive transfer) across in vitro and in vivo systems\",\n      \"pmids\": [\"21124939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"FcγRI mediates serum amyloid P (SAP)-induced inhibition of fibrocyte differentiation; deletion of FcγRI (CD64) in murine cells or siRNA-mediated knockdown in human cells significantly reduces sensitivity to SAP. The inhibitory receptor FcγRIIb increases sensitivity to SAP, whereas deletion of FcγRIIb, FcγRIIIa, and FcγRIV together does not affect SAP sensitivity.\",\n      \"method\": \"FcγRI-knockout murine cells; siRNA knockdown of FcγRI and FcRγ in human cells; fibrocyte differentiation assay; SAP mutagenesis (residues critical for FcγRIIa binding); genetic deletion combinations\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO and siRNA KD with specific functional readout (fibrocyte differentiation); single lab with multiple deletion combinations\",\n      \"pmids\": [\"22493081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"FcγRI (CD64) activation drives NF-κB-regulated NLRP3 inflammasome formation and IL-1β/IL-18 release; FcγRI-expressing Ba/F3 cells show increased NLRP3 inflammasome formation reversed by NF-κB inhibitor PDTC. Silencing FcγRI in THP-1 macrophages reduces NLRP3 inflammasome activation.\",\n      \"method\": \"FcγRI-expressing Ba/F3 cell model; NF-κB inhibitor (PDTC) treatment; siRNA knockdown of FcγRI in THP-1 macrophages; NLRP3 inflammasome protein expression; IL-1β and IL-18 ELISA\",\n      \"journal\": \"Life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function and loss-of-function with pathway inhibition linking FcγRI to NF-κB/NLRP3 axis; single lab\",\n      \"pmids\": [\"29920250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Crystal structure of human FcγRI in complex with IgG-Fc reveals the molecular basis for high-affinity binding; a receptor-glycan interaction involving the third extracellular domain contributes importantly to binding affinity. This structural work illuminates how the three-domain architecture of FcγRI achieves high affinity compared to two-domain low-affinity receptors.\",\n      \"method\": \"Structural determination (crystallography of FcγRI–IgG-Fc complex); structural analysis of receptor-glycan contacts\",\n      \"journal\": \"Immunological reviews\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — structural data (crystal structure) reported in a review/summary paper; the primary structure data is referenced but the abstract is a review without independent validation described\",\n      \"pmids\": [\"26497521\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Binding of monomeric IgG to FcγRI provides a low-intensity tonic signal necessary for full IFN-γ receptor signaling in the same cell. Engagement of FcγRI with larger immune complexes results in phagocytosis, reactive oxygen species generation, and inflammatory cytokine synthesis, but FcγRI engagement can also potently inhibit IFNγ and TLR4 signaling and induce IL-10 secretion depending on context.\",\n      \"method\": \"Review synthesizing published experimental evidence including receptor signaling studies (tonic signal, IFNγ receptor crosstalk, TLR4 inhibition assays)\",\n      \"journal\": \"Immunological reviews\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — review paper summarizing experimental findings from multiple sources; individual underlying experiments not independently assessable from this abstract alone\",\n      \"pmids\": [\"26497519\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"LILRB4 co-ligation with FcγRI significantly dephosphorylates key signaling proteins in the clathrin-mediated endocytosis and Fc-receptor phagocytosis pathways (including FcR γ-chain, Syk, clathrin, Cbl, HRS, TRIM21, and HSP70), suppressing antibody-opsonized bacterial particle uptake, demonstrating that tyrosine phosphorylation of these proteins is critical for FcγRI-dependent endocytosis/phagocytosis.\",\n      \"method\": \"Antibody ligation of FcγRI and/or LILRB4 on THP-1 cells; anti-phosphotyrosine immunoprecipitation; mass spectrometry peptide sequencing (Mascot); Ingenuity Pathway Analysis; bacterial particle phagocytosis assay\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phosphoproteomics by MS combined with functional phagocytosis readout; single lab\",\n      \"pmids\": [\"27725776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"FcγRI (FcγRIa, CD64) nanoclusters at macrophage surfaces are constitutively associated (within 62 ± 5 nm) with SIRPα nanoclusters via the actin cytoskeleton. Upon Fc receptor activation, Src-family kinase signaling causes segregation of FcγRI and SIRPα nanoclusters (to 197 ± 3 nm apart). Co-ligation of SIRPα with CD47 abrogates nanocluster segregation. If activation signals dominate, FcγRI nanoclusters reorganize into periodically spaced concentric rings.\",\n      \"method\": \"Dual-color direct stochastic optical reconstruction microscopy (dSTORM) super-resolution imaging; Src-family kinase inhibitor treatment; CD47-SIRPα co-ligation; actin cytoskeleton disruption\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — super-resolution structural imaging combined with pharmacological and co-ligation experiments with nanometer-scale precision, revealing mechanistic basis of signal integration\",\n      \"pmids\": [\"28289091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Cytokines (IL-3, TNFα, IFNγ) enhance FcγRI binding to immune complexes through 'inside-out' signaling that increases FcγRI nanoclustering in an actin-cytoskeleton-dependent manner. Chemical inhibition of PP1 phosphatase activity reduces FcγRI inside-out signaling (without altering FcγRI phosphorylation itself), and TNFα/IFNγ stimulation enhances neutrophil ADCC toward CD20-expressing tumor cells.\",\n      \"method\": \"Super-resolution imaging (single-particle tracking); PP1 phosphatase inhibitor (calyculin A); actin cytoskeleton disruption; cytokine stimulation (IL-3, TNFα, IFNγ); ADCC assay against CD20+ tumor cells\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — super-resolution imaging combined with pharmacological dissection of signaling and functional ADCC readout in primary human cells\",\n      \"pmids\": [\"30042128\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"FcγRI (CD64) expressed in a subpopulation of joint sensory neurons directly mediates acute joint hypernociception upon IgG immune complex crosslinking, independently of joint inflammation. FcγRI crosslinking directly activates somata and peripheral terminals of these neurons. Effects are diminished in global and sensory-neuron-specific Fcgr1 knockout mice. In murine inflammatory arthritis models, neuronal FcγRI signaling is upregulated and its acute blockade or genetic deletion attenuates arthritis pain without altering joint inflammation.\",\n      \"method\": \"Global and conditional (sensory neuron-specific) Fcgr1 knockout mice; IgG immune complex-induced joint hypernociception model; inflammatory arthritis models; electrophysiology of joint sensory neurons; pain behavioral assays\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO in sensory neurons with multiple behavioral and electrophysiological readouts demonstrating neuronal-cell-autonomous function, independent of immune cell FcγRI\",\n      \"pmids\": [\"31211699\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Deglycosylation of antibody-based radioimmunoconjugates impairs their binding to FcγRI (surface plasmon resonance, ELISA, flow cytometry), resulting in ~3.5-fold reduction in off-target liver uptake and improved tumor-to-organ contrast in PET imaging in humanized NSG mice, demonstrating that FcγRI-mediated sequestration in immune cells drives hepatic off-target uptake of radioimmunoconjugates.\",\n      \"method\": \"Surface plasmon resonance (SPR); ELISA; flow cytometry; 89Zr-labeling; PET imaging; biodistribution in athymic nude, NSG, and humanized NSG mice bearing HER2+ xenografts\",\n      \"journal\": \"Journal of nuclear medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct SPR binding plus in vivo functional consequence (biodistribution) with three mouse model types; multiple orthogonal methods\",\n      \"pmids\": [\"30733320\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"FcγRI potentiates HIV-1 neutralization by antibodies targeting the gp41 NHR region >5,000-fold in TZM-bl cells expressing FcγRI compared to cells without it, enabling neutralization of tier-2 viruses. This FcγRI-dependent potentiation is also observed with antisera from guinea pigs immunized with an NHR-based vaccine candidate.\",\n      \"method\": \"Neutralization assay in TZM-bl cells with and without FcγRI expression; comparison of tier-1 and tier-2 virus neutralization; guinea pig immunization with (ccIZN36)3 vaccine; FcγRI-blocking controls\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-based neutralization assay with FcγRI-expressing vs. control cells plus in vivo antisera testing; single lab\",\n      \"pmids\": [\"33431684\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"FCGR1A variants affect CD64 function: (1) SNV rs1848781 in the proximal promoter region associates with CD64 expression levels (confirmed by promoter reporter assay showing higher activity of G vs C allele); (2) rs587598788 indel in intron 5 associates with CD64 expression; (3) non-synonymous SNV rs1050204 (p.D324N) significantly affects CD64-mediated phagocytosis, degranulation, and pro-inflammatory cytokine production.\",\n      \"method\": \"Promoter reporter assay; genotype-phenotype association analysis; functional assays for CD64-mediated phagocytosis, degranulation, and cytokine production with rs1050204 variant\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter reporter assay plus functional phagocytosis/cytokine assays for coding variant; single lab, human genetic variants\",\n      \"pmids\": [\"35371020\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CD64 overexpression in allogeneic iPSC-derived endothelial cells enables escape from antibody-mediated killing (ADCC and complement-dependent cytotoxicity) by capturing monomeric IgG and occupying Fc regions. An intracellularly truncated CD64 analog (CD64t) retains this protective function, demonstrating that Fc capture rather than intracellular signaling is the mechanistic basis of protection.\",\n      \"method\": \"In vitro ADCC and complement-dependent cytotoxicity assays; humanized mouse ADCC models; overexpression of full-length CD64 vs. intracellularly truncated CD64t; iPSC-derived endothelial cells, thyroid epithelial cells, beta cells, and CAR T cells\",\n      \"journal\": \"Nature biotechnology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — truncation mutagenesis distinguishing signaling from IgG-capture function, validated in multiple cell types and in vivo humanized mouse models\",\n      \"pmids\": [\"36593395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Neuronal FcγRI in dorsal root ganglion (DRG) neurons mediates neuropathic pain; sciatic nerve injury persistently activates FcγRI-related signaling in DRG, and conditional knockout of Fcgr1 in DRG neurons significantly alleviates neuropathic pain. CRP, which increases in DRG after nerve injury, evokes pain by activating neuronal FcγRI. Microinjection of naive IgG into DRG alleviates neuropathic pain by suppressing neuronal FcγRI activation, indicating IgG acts as a competitive inhibitor at neuronal FcγRI.\",\n      \"method\": \"Conditional knockout (CKO) of Fcgr1 in DRG neurons (rat model); nerve injury model (CCI); DRG microinjection of CRP and naive IgG; behavioral pain assays; FcγRI signaling pathway analysis in DRG neurons\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — neuron-specific conditional KO with multiple mechanistic interventions (CRP, IgG injection) and behavioral readouts establishing neuronal FcγRI signaling in pain\",\n      \"pmids\": [\"36727833\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Guselkumab, via its native Fc domain, binds FcγRI (CD64) on IFN-γ-primed monocytes and simultaneously captures IL-23 secreted from CD64+ IL-23-producing macrophages, mediating IL-23 internalization into low-pH intracellular compartments. This Fc-mediated CD64 binding enhances potency for inhibiting IL-23 signaling in a co-culture system where IL-23 is produced by CD64+ cells, compared to risankizumab (which has Fc mutations abrogating FcγR binding).\",\n      \"method\": \"Flow cytometry (Fc-mediated binding to CD64+ monocytes); live-cell confocal imaging (IL-23 internalization into low-pH compartments); co-culture of IL-23-producing CD64+ THP-1 cells with IL-23-responsive reporter cells; Fc-blocking controls\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — live imaging plus co-culture functional assay with Fc-blocking controls; single lab, in vitro only\",\n      \"pmids\": [\"40145093\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"FcγRI (CD64, FCGR1A) is the sole human high-affinity IgG Fc receptor, functioning as a complex of a three-extracellular-domain α-chain (domains 2 and 3 conferring high-affinity IgG binding) with the FcR γ-chain, which supplies the ITAM required for phagocytosis, ADCC, and most signaling; the α-chain cytoplasmic tail, phosphorylated on serine residues, modulates kinetics of endocytosis and cytokine specificity through interactions with periplakin, constitutively resides in lipid rafts, and contains autonomous targeting information directing antigen to MHC class II compartments independently of the γ-chain ITAM; cytokine-driven 'inside-out' signaling clusters FcγRI nanoclusters via the actin cytoskeleton (regulated by PP1 phosphatase), enhancing immune complex binding, while activation segregates FcγRI from inhibitory SIRPα nanoclusters; downstream signaling proceeds through a PLD1→sphingosine kinase-1 cascade (distinct from FcγRIIA's PLCγ1 pathway), activates NF-κB/NLRP3 inflammasome, and differentially recruits PKC isoenzymes depending on cell differentiation state; beyond classical myeloid cells, FcγRI expressed in sensory neurons directly mediates IgG immune complex-induced joint pain and neuropathic pain through neuronal CRP/FcγRI signaling, and CRP binds FcγRI with affinity enhanced ~30-fold by the γ-chain, triggering phagocytosis and PLD activation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"FCGR1A (Fcγ RI, CD64) is the high-affinity IgG Fc receptor that drives antibody-dependent effector functions of myeloid cells, including phagocytosis, ADCC, antigen presentation, and proinflammatory cytokine output [#8, #9]. High-affinity, IgG-subclass-specific binding is conferred by the receptor's extracellular domains 2 and 3, with domain 1 supporting conformational stability and a domain-3 receptor-glycan contact contributing to affinity [#3, #23]. The α-chain itself lacks signaling motifs: phagocytosis, ADCC, and enhancement of immune-complex viral infectivity all require an ITAM supplied in trans by the associated FcR γ-chain (or, in its absence, by Fcγ RIIa), and abrogating that ITAM uncouples signaling from receptor engagement [#0, #2, #13, #15]. The α-chain cytoplasmic tail carries an autonomous, γ-chain-independent function: it is constitutively serine-phosphorylated, sets the kinetics of endocytosis/phagocytosis and the calcium dependence and cytokine specificity of responses (notably IL-6 secretion), and routes internalized antigen to MHC class II late-endosomal compartments — activities mediated in part through a selective interaction with periplakin [#4, #5, #7, #11, #12]. Downstream of aggregation, Fcγ RI signals through a phospholipase D1→sphingosine kinase-1 cascade distinct from the PLCγ1 pathway of Fcγ RIIa, recruits PKC isoenzymes in a differentiation-state-dependent manner, and drives NF-κB-regulated NLRP3 inflammasome activation and IL-1β/IL-18 release [#6, #19, #22]. The receptor resides constitutively in lipid rafts and organizes into nanoclusters whose immune-complex avidity is tuned by cytokine-driven, actin-dependent 'inside-out' signaling (regulated by PP1) and whose proximity to inhibitory SIRPα nanoclusters reorganizes upon activation [#17, #26, #27]. C-reactive protein is a non-IgG ligand that binds the Fcγ RI extracellular region with affinity strongly enhanced by the γ-chain, triggering phagocytosis and PLD activation [#10, #16]. Beyond myeloid cells, Fcγ RI in sensory neurons cell-autonomously mediates IgG immune-complex-induced joint pain and CRP-driven neuropathic pain [#28, #33]. Coding and regulatory FCGR1A variants modulate CD64 expression and effector function [#31].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Established that Fcγ RI lacks intrinsic signaling capacity and depends on an associated subunit, answering how a receptor with a short tail triggers phagocytosis.\",\n      \"evidence\": \"COS-1 reconstitution of wild-type and cytoplasmic-deletion Fcγ RI with the Fcγ RIIIA γ-subunit plus tyrosine kinase inhibitor studies\",\n      \"pmids\": [\"7516890\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the γ-chain ITAM tyrosines required\", \"Phagocytosis assayed in a non-myeloid heterologous cell line\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Mapped expression and IgG-affinity determinants to the extracellular region and showed conserved γ-chain association across species, framing the structural basis of high-affinity binding.\",\n      \"evidence\": \"Kinetic binding analysis of NOD vs BALB/c Fcγ RI, COS-7 extracellular domain-swap chimeras, and co-transfection with the Fcε RI γ-subunit\",\n      \"pmids\": [\"8663283\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mouse receptor; human affinity determinants inferred\", \"Mechanism linking extracellular mutations to surface expression unresolved\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Defined that an intact ITAM in either the γ-chain or Fcγ RIIa is essential for triggering phagocytosis and ADCC, and that extracellular domains 2/3 confer high-affinity subclass-specific binding.\",\n      \"evidence\": \"ITAM mutagenesis and reconstitution in IIA1.6 cells with phagocytosis/ADCC readouts; domain-swap chimeras with monomeric IgG binding\",\n      \"pmids\": [\"9737671\", \"9881694\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve which kinases read the ITAM\", \"Domain-3 glycan contribution not yet identified\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Resolved an autonomous, γ-chain-independent role for the α-chain cytoplasmic tail in trafficking and cytokine specificity, distinguishing it from the ITAM-driven phagocytic signal.\",\n      \"evidence\": \"IIA1.6 and macrophage transfectants with tail-deletion and ITAM-mutant constructs, immunoelectron microscopy, MHC-II antigen presentation, calcium and cytokine assays; PKC isoenzyme fractionation in differentiated U937 cells\",\n      \"pmids\": [\"10397749\", \"10514529\", \"10233728\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trafficking motifs within the tail not pinpointed\", \"Link between PKC isoenzyme usage and downstream phospholipases not directly tested\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Established constitutive serine phosphorylation of the α-chain tail as a regulatory layer and demonstrated the receptor's non-redundant in vivo roles in effector function and antibody control.\",\n      \"evidence\": \"Serine→alanine and truncation mutants in P388D1 macrophages with okadaic acid; Fcγ RI knockout mice across hypersensitivity, arthritis, and infection models; CRP direct binding by SPR and functional phagocytosis/PLD assays\",\n      \"pmids\": [\"12200451\", \"11911824\", \"11911823\", \"12383205\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Serine kinase(s) acting on the tail not identified\", \"CRP versus IgG binding-site overlap on the receptor unresolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identified periplakin as a selective α-chain cytoplasmic-tail partner controlling ligand binding and trafficking, and dissected receptor-proximal kinase differences from Fcγ RIIa.\",\n      \"evidence\": \"Reciprocal co-IP, blot-overlay, alanine-scanning and TAT-peptide interference for periplakin; Syk/Hck/Lyn co-IP and γ-chain-independent Fcγ RIIa-ITAM phagocytosis in COS cells\",\n      \"pmids\": [\"15229321\", \"15161926\", \"15075346\", \"15136586\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How periplakin mechanistically alters ligand-binding capacity unclear\", \"Functional significance of weaker Syk recruitment in primary myeloid cells not established\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showed that Fcγ RI signaling competency (γ-chain ITAM) is required for antibody-dependent enhancement of dengue infectivity, extending its functional repertoire beyond simple uptake.\",\n      \"evidence\": \"Site-directed ITAM mutagenesis in COS-7 with dengue plaque and flow-cytometric infectivity readouts versus Fcγ RIIa\",\n      \"pmids\": [\"17005690\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signaling step coupling ITAM to enhanced viral entry unresolved\", \"Heterologous cell system may not reflect primary monocytes\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Quantified γ-chain enhancement of CRP binding (~30-fold), revealing a transmembrane contribution to non-IgG ligand engagement.\",\n      \"evidence\": \"Single-molecule confocal binding kinetics in COS-7 cells expressing Fcγ RI alone or with γ-chain\",\n      \"pmids\": [\"17255341\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of γ-chain transmembrane contribution not defined\", \"Single lab, heterologous cells\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Localized Fcγ RI to lipid rafts and demonstrated a soluble receptor decoy strategy, addressing membrane organization and therapeutic potential.\",\n      \"evidence\": \"Detergent-insoluble membrane fractionation and GM1 co-patching; recombinant soluble Fcγ RIA SPR binding plus mast-cell cytokine, Arthus, and arthritis models\",\n      \"pmids\": [\"18207250\", \"18097060\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of raft residence for signaling not fully defined\", \"Decoy efficacy translation to human disease untested\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined a Fcγ RI-specific PLD1→sphingosine kinase-1 signaling axis driving inflammatory mediators and MHC-II trafficking, distinct from Fcγ RIIa's PLCγ1 pathway.\",\n      \"evidence\": \"Pharmacological PLD1/SK1 inhibition, HLA-DM compartment co-localization, cytokine and antigen-presentation assays in U937 cells and primary human monocytes\",\n      \"pmids\": [\"19420354\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Connection between γ-chain ITAM and PLD1 activation not mapped\", \"Inhibitor-based pathway dissection lacks genetic confirmation\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Revealed an IgG-independent role of the α-chain cytoplasmic tail in bacterial OmpA recognition and identified Fcγ RI as a control point in fibrocyte differentiation, broadening its ligand and effector scope.\",\n      \"evidence\": \"Fcγ RIa knockout mice in E. coli K1 meningitis with tail-truncation, γ-chain recruitment co-IP, phosphorylation analysis, and adoptive transfer; Fcγ RI KO/siRNA in SAP-driven fibrocyte differentiation assays\",\n      \"pmids\": [\"21124939\", \"22493081\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signaling pathway downstream of OmpA-induced phosphorylation undefined\", \"SAP-Fcγ RI binding interface not characterized\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Linked Fcγ RI activation to NF-κB-dependent NLRP3 inflammasome assembly and IL-1β/IL-18 release, connecting the receptor to inflammasome biology.\",\n      \"evidence\": \"Gain-of-function in Ba/F3 cells with PDTC inhibition and siRNA knockdown in THP-1 macrophages with inflammasome protein and cytokine readouts\",\n      \"pmids\": [\"29920250\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Intermediate signaling between Fcγ RI and NF-κB not mapped\", \"Single lab\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Provided structural and signaling-context detail: a crystal structure of the IgG-Fc complex implicating a domain-3 glycan contact, and a model of monomeric-IgG tonic signaling versus immune-complex activation.\",\n      \"evidence\": \"Crystallography of the Fcγ RI–IgG-Fc complex (reported in review); review synthesis of tonic signaling and IFN-γ/TLR4 crosstalk experiments\",\n      \"pmids\": [\"26497521\", \"26497519\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural data reported within a review without independent validation here\", \"Tonic-signaling mechanism summarized rather than directly demonstrated\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Used phosphoproteomics to define the tyrosine-phosphorylation network required for Fcγ RI endocytosis/phagocytosis and showed inhibitory LILRB4 co-ligation dephosphorylates it.\",\n      \"evidence\": \"Fcγ RI/LILRB4 ligation in THP-1 cells with anti-phosphotyrosine IP, mass spectrometry, and phagocytosis assay\",\n      \"pmids\": [\"27725776\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct substrates of LILRB4-recruited phosphatase not pinpointed\", \"Single lab\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrated cytokine-driven, actin- and PP1-dependent 'inside-out' nanoclustering as the mechanism by which Fcγ RI avidity for immune complexes is dynamically tuned, with functional consequences for ADCC.\",\n      \"evidence\": \"Super-resolution single-particle tracking, PP1 inhibition (calyculin A), actin disruption, cytokine priming, and CD20+ tumor ADCC assay\",\n      \"pmids\": [\"30042128\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How PP1 controls clustering without altering receptor phosphorylation unresolved\", \"Identity of clustering scaffold proteins not defined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Resolved spatial integration of activating and inhibitory signals by imaging constitutive Fcγ RI–SIRPα nanocluster association and their activation-dependent segregation.\",\n      \"evidence\": \"Dual-color dSTORM super-resolution imaging with Src-family kinase inhibition, CD47-SIRPα co-ligation, and actin disruption\",\n      \"pmids\": [\"28289091\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular tether linking the two nanocluster types not identified\", \"Functional output of concentric-ring reorganization not quantified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established a cell-autonomous neuronal function for Fcγ RI in sensory neurons, mediating IgG immune-complex-induced joint pain independent of inflammation.\",\n      \"evidence\": \"Global and sensory-neuron-specific Fcgr1 knockout mice with electrophysiology and pain behavioral assays in immune-complex and arthritis models\",\n      \"pmids\": [\"31211699\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream neuronal signaling and ion-channel coupling undefined\", \"Whether γ-chain participates in neurons not addressed\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showed that Fcγ RI-mediated IgG sequestration in immune cells drives hepatic off-target uptake of radioimmunoconjugates, a pharmacological consequence of high-affinity Fc binding.\",\n      \"evidence\": \"SPR, ELISA, flow cytometry, and PET biodistribution of glycosylated vs deglycosylated conjugates in athymic, NSG, and humanized NSG mice\",\n      \"pmids\": [\"30733320\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular site of hepatic sequestration not fully resolved\", \"Relevance to fully human contexts inferred from humanized mice\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrated that Fcγ RI expression dramatically potentiates antibody neutralization of HIV-1, indicating a role for the receptor in antiviral antibody function.\",\n      \"evidence\": \"Neutralization assays in TZM-bl cells with/without Fcγ RI, tier-1/tier-2 virus comparison, and guinea pig immune sera with Fcγ RI-blocking controls\",\n      \"pmids\": [\"33431684\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of potentiation (capture vs signaling) not dissected\", \"Single lab, cell-based\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Linked FCGR1A genetic variation to CD64 expression and effector function, providing human genetic evidence for functional modulation.\",\n      \"evidence\": \"Promoter reporter assays and genotype-phenotype association plus phagocytosis/degranulation/cytokine assays for the p.D324N coding variant\",\n      \"pmids\": [\"35371020\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which p.D324N alters function not defined\", \"Variant effects on clinical phenotypes not established\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Separated the IgG-capture function from intracellular signaling and extended neuronal Fcγ RI to neuropathic pain, clarifying both engineering applications and pain mechanisms.\",\n      \"evidence\": \"Full-length vs intracellularly truncated CD64 overexpression in iPSC-derived cells with ADCC/CDC and humanized mouse models; DRG-neuron-specific Fcgr1 conditional knockout with CRP/IgG microinjection and pain behavior\",\n      \"pmids\": [\"36593395\", \"36727833\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Neuronal Fcγ RI signaling effectors not fully mapped\", \"Whether neuronal CRP signaling uses the γ-chain unresolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Showed therapeutic antibody Fc engagement of CD64 can mediate cytokine capture and internalization, demonstrating an Fc-CD64 axis exploitable for drug potency.\",\n      \"evidence\": \"Flow cytometry, live-cell confocal imaging of IL-23 internalization, and CD64+ THP-1 co-culture reporter assays with Fc-blocking controls (guselkumab vs risankizumab)\",\n      \"pmids\": [\"40145093\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vitro only; in vivo relevance untested\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the α-chain cytoplasmic tail, serine phosphorylation, periplakin, and the γ-chain ITAM are mechanistically integrated to specify divergent outcomes (phagocytosis vs antigen routing vs cytokine programs vs neuronal pain) remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified signaling model connecting tail phosphorylation to PLD1/SK1 and inflammasome outputs\", \"Neuronal Fcγ RI downstream effectors and γ-chain dependence undefined\", \"Structural basis of nanocluster scaffolding and SIRPα tethering unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0001618\", \"supporting_discovery_ids\": [15, 30]},\n      {\"term_id\": \"GO:0038024\", \"supporting_discovery_ids\": [4, 9, 32]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 2, 19]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [11, 12]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [11, 17, 26]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [4, 19]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [8, 9, 19]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [4, 5, 25]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [19, 22, 26]}\n    ],\n    \"complexes\": [\"Fcγ RI α-chain / FcR γ-chain complex\"],\n    \"partners\": [\"FCER1G\", \"FCGR2A\", \"PPL\", \"SIRPA\", \"CRP\", \"SYK\", \"LILRB4\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}